Medical Devices

New York, September 2023: According to a new research study by Global Insight Services (GIS), the Wound Closure Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 17.7 billion by 2032.

Wound closure devices are those that help to close a wound. It works by drawing the wound edges and tissues jointly to aid in healing. There are several products on the market that aid with wound closure. Strips, mechanical wound closure devices, adhesives, staples, and sutures are some of the most common wound closure devices. These devices aid in the strengthening of injured tissue as well as the reduction of tissue damage. Furthermore, they aid in reducing the chance or hazard of severe scarring and infection.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS25736/

Wound Closure Devices Market: Market Drivers and Trends

The rising frequency of chronic wounds that consist of diabetic foot ulcers, venous leg ulcers, and pressure ulcers is expected to drive demand for wound closure devices. According to B. Braun Melsungen AG research, diabetic foot ulcers afflict between 2.0% to 10.0% of patients with diabetes. Furthermore, according to the American College of Physicians, the global yearly incidence of diabetic foot ulcers in 2017 was roughly 6.3%, and the lifetime risk of foot ulcers in diabetic individuals ranged from 19.0% to 34.0%. According to the National Centre for Biotechnology Information (NCBI), the prevalence rate of diabetic foot ulcers in North America in 2017 reached 13.0% (highest), which was 5.5% in Asia, 7.2% in Africa, 5.1% in Europe, and 13.0% in the United States. Chronic wounds are treated using wound closure devices which include sutures, staples, and mechanical wound closure systems.

Furthermore, there has been an increase in the total number of surgical operations performed throughout the world in recent years. One of the primary causes driving an increase in the number of procedures is the rising prevalence of chronic conditions such as cancer, diabetes, and autoimmune disorders. Infectious and non communicable illnesses have become more common in recent decades. These drivers are likely to propel market expansion.

Wound Closure Devices Market: Market Restraints and Challenges

The high rivalry that leads to pricing pressure is one of the major hurdles to the worldwide wound closure devices market’s growth. The market is accessible to small businesses for producing wound closure goods that include sutures, hemostats, surgical staples, and tissue sealants, despite the fact that few big manufacturers dominate a few product groups. When opposed to large, branded enterprises with names like Ethicon and Covidien (Medtronic), local competitors produce and distribute these items at much-reduced costs. Devices that are accessible at a low cost in developing nations are projected to increase faster. However, sophisticated items of greater quality are preferred by industrialized countries. Hence, these factors are expected to restrain growth of the market during the forecast period.

Wound Closure Devices Market Report Findings

https://www.globalinsightservices.com/reports/wound-closure-devices-market/

The acute segment is likely to hold the major share of the market in 2022

Based on wound type, the Wound Closure Devices Market is segmented into chronic and acute. The acute segment is expected to dominate the market during the forecast period. This is due to an increase in the number of operations and burn cases worldwide. According to WHO, around USD 26.00 million are allocated each year in South Africa for the treatment of burns caused by kerosene cooking burner events. Such severe injuries need prompt treatment using cutting-edge medical technology. Poverty, a lack of basic safety precautions, the use of paraffin for non-electric home appliances, alcohol misuse, and smoking are the key causes of a large number of burn cases.

The sutures segment is likely to hold the major share of the market in 2022

By product, the market is classified into adhesives, staples, sutures, strips, sealants, and mechanical wound closure devices. The sutures segment is further segmented into absorbable, and non-absorbable. Also, the strips segment is further bifurcated into sterile, and non-sterile. Similarly, sealants is sub-segmented into synthetic, non-synthetic, and collgen-based. The sutures segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. attributable to the increased frequency of incidents around the globe. Sutures are needles with thread connected to them that come in a range of forms, sizes, and thread materials. Sutures are further classified as absorbable or non-absorbable. The absorbable suture market is expected to develop the quickest throughout the forecast period because they are far more convenient and easier to use than non-absorbable sutures.

The hospital segment is likely to hold the major share of the market in 2022

Based on end-user, the Wound Closure Devices Market is segmented into hospitals, hospitals, clinics, trauma centers, and others. In 2022, the hospital segment dominated the market in terms of revenue and is expected to be the same during the upcoming years. This is attributed to the increased number of operations and increasing occurrences of road accidents. According to WHO, nearly 1.35 million people die each year in traffic accidents, which cost most nations nearly 3.0% of their GDP.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Wound Closure Devices Market value followed by Asia Pacific. This is because of the presence of key actors in the region, as well as the increased frequency of chronic wounds. Furthermore, the growing number of patients having procedures and growing knowledge about surgeries that are minimally invasive are driving regional market expansion. 3M, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Medtronic, and Baxter are key participants in the North American market. These firms are making investments in R&D to create medical gadgets that help speed up wound closure.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS25736/

Competitive Landscape

The key players studied in the Wound Closure Devices Market are 3M, Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Medtronic, Baxter, Integra LifeSciences Corporation, Smith & Nephew, Mölnlycke Health Care AB, Medline Industries, Inc., and AVITA Medical among others.

Wound Closure Devices Market: Recent Developments

• In June 2021, Ethicon Plus sutures were the first to be approved for use in the NHS by NICE Medical Technologies Guidance as they have been demonstrated to lower the possibility of surgical site infections (SSIs) by over 30%.
• In November 2020, Trubarb, a knotless tissue closure device launched by Healthium, is an efficacious triangular end stopper that removes the need for knotting as compared to a normal suture.
• In March 2020, LiquiBand Plus, developed by Advanced Medical Solutions Limited, was approved by the FDA to heal readily approximated skin margins of wounds after surgical incisions.
• In February 2020, Wego-Stainless Steel suture was approved by the FDA for applications such as abdominal wound closure, hernia repair, and sternal closure by Foosin Medical Supplies Inc., Ltd.

Wound Closure Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Wound Closure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future global Wound Closure Devices Market potential from 2022 to 2032 in terms of revenue ($ Million) and Volume (Units).
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the global Wound Closure Devices Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Wound Closure Devices Market industry.

Wound Closure Devices Market Segmentation

By Wound Type

• Chronic
• Acute

By Product

• Adhesives
• Staples
• Sutures
  • Absorbable
  • Non-Absorbable
• Strips
  • Sterile
  • Non-Sterile
• Sealants
  • Synthetic
  • Non-synthetic
  • Collagen-based
• Mechanical Wound Closure Devices

By End-User

• Hospital
• Clinics
• Trauma centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• 3M
• Johnson & Johnson Services, Inc.
• B. Braun Melsungen AG
• Medtronic
• Baxter
• Integra LifeSciences Corporation
• Smith & Nephew
• Mölnlycke Health Care AB
• Medline Industries, Inc.
• AVITA Medical

New York, September 2023: According to a new research study by Global Insight Services (GIS), the Meniscus Repair System Market is expected to grow rapidly over the next 10 years to reach a value of more than US$ 1.1 billion by 2032.

A meniscus rupture is a frequent injury to the meniscus, which is a component of the knee. In the knee joint, the menisci consist of two crescent-shaped pads of thick, rubbery shock-absorbing cartilage. The Meniscal Repair System is designed for use during meniscal repair and allograft transplant surgeries. An outpatient surgical approach to replace damaged knee cartilage is arthroscopic meniscus repair. A torn meniscus is treated using a number of minimally invasive procedures, and recovery requires postoperative protection. These systems are generally comprised of a collection of specialized equipment and gadgets utilized during arthroscopic surgery for fixing the meniscus. Meniscus repair systems of many varieties are available on the market, including all-inside meniscal repair systems, outside-in meniscal repair systems, and others.

Request Sample Pages of this Research Report

https://www.globalinsightservices.com/request-sample/GIS25735/

Meniscus Repair System Market: Market Drivers and Trends

Increased technical progress and research & development activities by market-leading players in the industry of meniscus repair implants and systems drive market expansion. In recent years, advancements in minimally invasive arthroscopy procedures have become the norm for meniscus surgery, since they allow for smaller incisions and quicker recovery periods. For example, Arthrex Inc.’s Meniscal Root Avulsions technology allows for less invasive RetroConstruction repair, which helps to preserve bone while completing meniscal root repair. In addition, biological implants produced from animal tissue, synthetic materials are being utilized to fix, or substitute damaged meniscus tissue. These drivers are likely to propel market expansion.

Meniscus Repair System Market: Market Restraints and Challenges

The high cost of meniscus repair operations, on the other hand, is expected to limit the widespread use of meniscus repair systems throughout the projection period. Meniscus repair procedures are expensive because they need specialized medical equipment and technology, such as robotic-aided surgery systems and arthroscopy tools. Furthermore, meniscus repair operations are sophisticated and need the expertise of a professional surgeon, whose services might be pricey. As a result, the high surgical costs are unaffordable for a small number of patients, limiting market expansion. For example, the cost of meniscal tear surgery ranges between $7,400 and $9,000, depending on the patient’s age. Furthermore, meniscus repair devices, surgery, and other associated costs add to the entire cost of surgery. As a result, the high cost of meniscus repair procedures stifles market growth. Hence, these factors are expected to restrain growth of the market during the forecast period.

Meniscus Repair System Market Report Findings

https://www.globalinsightservices.com/reports/meniscus-repair-system-market/

The all-inside meniscal repair system segment is likely to hold the major share of the market in 2022

Based on product type, the Meniscus Repair System Market is segmented into an all-inside meniscal repair system, inside-out meniscal repair system, an outside-in meniscal repair system, and meniscal root repair system. The all-inside meniscal repair system segment is expected to dominate the market during the forecast period. All-inside meniscal repair technologies decrease technical difficulties, surgical time, and neuro-vascular structural danger. Furthermore, such technologies eliminate the hazards related to secondary incisions, shorten operational times, and make implant placement easier. As a result, increased benefits associated with all-inside meniscus repair methods, as well as a spike in its adoption rate, are expected to boost segment growth.

The radial tier segment is likely to hold the major share of the market in 2022

By application, the market is classified into radial tear, flap tear, horizontal tear, complex tear, and others. The radial tear segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. Radial meniscus tears have grown increasingly prevalent, particularly in sports traumatology. According to Johns Hopkins Medicine, nearly 3.5 million children aged 14 and under are injured each year while participating in leisure activities or sports. Suture method advancements in healing radial meniscal tears are expected to drive market expansion.

The hospitals segment is likely to hold the major share of the market in 2022

Based on end-user, the Meniscus Repair System Market is segmented into hospitals, ambulatory surgical centers, specialized orthopedic clinics, and others. In 2022, the hospitals segment dominated the market in terms of revenue and is expected to be the same during the upcoming years. This is because of the expanding number of healthcare facilities that have technologically improved technologies for performing knee-related meniscal operations. According to WHO data, 73% of highly specialized hospitals conducted more than 3000 procedures each year, compared to 18% of low-specialization institutions. Furthermore, expanding health insurance for the patient population is predicted to increase the number of surgical operations, boosting market development.

The North America region is accounted for the majority of market share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America has the biggest market share in terms of Meniscus Repair System Market value followed by Asia Pacific. This is due due to an increase in the number of people suffering from orthopedic illnesses such as osteoarthritis and sports-related injuries. Furthermore, an increase in the number of meniscus repair procedures is expected to boost market development. For example, according to the Journal of Orthopaedic Research, released in March 2021, over 8,50,000 meniscus repair procedures were conducted in the United States each year. Furthermore, an increase in the frequency of sports injuries leads to an increase in the prevalence of meniscus tears. As a result, this aspect is expected to boost market expansion. For example, according to data released by Johns Hopkins Medicine, more than 3.5 million children aged 14 and younger are injured each year while participating in sports or leisure activities. As a result, this factor increases the likelihood of knee injuries and meniscus tears, fueling market expansion.

Have a question for our analyst

https://www.globalinsightservices.com/inquiry-before-buying/GIS25735/

Competitive Landscape

The key players studied in the global Meniscus Repair System Market are Healthium Medtech , Smith & Nephew plc, Stryker Corporation , Arthrex, Inc. , Double Medical Technology Inc. , Zimmer Biomet Holding Inc., Arcuro Medical, Chetan Meditech Pvt. Ltd., Johnson & Johnson, and CONMED Corporation others.

Meniscus Repair System Market: Recent Developments

• In 2022, For treating meniscus joints, Arthrex, Inc designed an anterior approach with the FiberStitch implant. The FiberStitch implant is a novel all-inside meniscal repair technique that uses soft suture sheaths instead of hard PEEK implants. The 2-0 FiberWire suture is used for arthroscopic all-suture meniscus repair.
• In July 2021, Smith & Nephew plc has introduced the FAST-FIX FLEX meniscal repair technology, which has a bending needle and shaft. It is utilized in meniscus repair and offers patients long-term advantages. As a result, the introduction of the FAST-FIX FLEX Meniscal Repair System will assist the firm in establishing a solid presence in the meniscus repair system industrial market.
• In June 2020, Arcuro Medical collaborated with Genesis Biologics, a healthcare supply firm, to promote and sell the SuperBall meniscus repair device throughout the United States. As a result, this aspect is related to the growth of the meniscus repair system market.

Meniscus Repair System Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Meniscus Repair System Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Meniscus Repair System Market in terms of revenue ($Billion).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Meniscus Repair System industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Meniscus Repair System Market along with the current trends and future estimations to depict imminent investment pockets. The overall Meniscus Repair System industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Meniscus Repair System Market are also analyzed.

Meniscus Repair System Market Segmentation

By Product Type

• All-inside Meniscal Repair System
• Inside-out Meniscal Repair System
• Outside-in Meniscal Repair System
• Meniscal Root Repair System

By Application

• Radial tear
• Horizontal tear
• Vertical tear
• Complex tear
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers
• Specialized Orthopedic Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Healthium Medtech
• Smith & Nephew plc
• Stryker Corporation
• Arthrex, Inc.
• Double Medical Technology Inc.
• Zimmer Biomet Holding Inc.
• Arcuro Medical
• Chetan Meditech Pvt. Ltd.
• Johnson & Johnson
• CONMED Corporation

Telemedicine Market to Reach US$ 94.5 Bn by 2032, driven by increasing demand for radiological services owing to high prevalence of chronic diseases: Global Insight Services

New York, August 2023: According to a new research study by Global Insight Services (GIS), the global telemedicine market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 94.5 Billion by 2032.

Telemedicine, also known as telehealth or e-medicine, is the remote delivery of healthcare services via telecommunications infrastructure, such as exams and consultations. According to recent research, 90% of organisations have already started or implemented telemedicine programmes. Even small, independent medical practises are beginning to embrace telemedicine in order to compete with local retail clinics and stop losing patients.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10073/

Telemedicine Market: Key Trends and Drivers

Surging prevalence of chronic diseases and cost-benefits of telemedicine will propel the market expansion. For instance, according to the US CDC, chronic diseases are major causes of death and disability globally and are strong contributors to the rise in annual healthcare expenditures. The management of chronic diseases requires constant monitoring and therapy to slow their progress. Telehealth and telemedicine, especially remote patient monitoring (RPM)/tele-homecare, are capable of improving patient self-management, medication compliance, clinical outcomes, and patient & provider satisfaction while reducing emergency room visits, hospital admissions, primary care utilization, long-term care, home admissions, and patient travel costs. These advantages are driving the demand for telehealth among end-users.

Telemedicine Market: Restraints & Challenges

Healthcare fraud is an important factor to consider in telehealth and telemedicine practises. A patient or a physician can be victimised in a variety of ways, such as when the physician’s name and accounts are used to receive payments from the insurance company, or when non-eligible or non-listed institutional providers practise improper coding and billing for false claims. Such fraudulent activities can erode trust and credibility in telehealth and telemedicine services. Victimized patients also have a tendency to share their negative experiences in the media, which affects many new entrants, limiting market growth.

Telemedicine Market Report Findings

https://www.globalinsightservices.com/reports/telemedicine-market/

The telemonitoring segment is likely to hold a dominant telemedicine market share and grow at a substantial CAGR during the forecast period.

Based on service, it is segmented into the tele-consulting, tele-monitoring, and tele-education/training. The tele-consulting segment accounted for the largest share of the global telemedicine market in 2022. The large share of the segment can be attributed to the growing demand for home-based remote monitoring service will boost the number of tele-consultations. Moreover, rising geriatric population base and increasing demand for home-based remote monitoring service. Remote telehealth monitoring programs are been initiated by several governments that focused on improving medication management and improves disease management at homecare setting. This will increase the demand for tele-consultation service. Furthermore, increasing need for providing healthcare services to patient at remote places coupled with rising demand for saving travel time will propel the segment growth.

The telehome segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on type, it is segmented into telehospital, and telehome. The telehospital segment is likely to dominate the market during the forecast period. This is due to increasing adoption and usage of telemedicine services in hospital setting to consult various specialists by doctors. This will result in cost savings for the hospitals as well as for the patients. The convenience and efficiency offered by telehospital services, such as remote consultations, virtual monitoring, and remote diagnostic capabilities, have garnered substantial attention from both healthcare providers and patients. The segment’s growth is expected to persist as advancements in technology, regulatory support, and the increasing acceptance of remote healthcare services continue to drive its adoption, ultimately reshaping the way healthcare is accessed and delivered on a global scale. Also, increasing government funding and grants for encouraging adoption of telemedicine services in hospitals will boost the segment demand.

The gynaecology segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on specialty, it is segmented into cardiology, gynecology, neurology, orthopedics, dermatology, mental health, and others. The cardiology segment is likely to dominate the market during the forecast period. This is owing to high With advances in remote monitoring technology and the increasing adoption of virtual healthcare platforms, patients and healthcare providers are recognizing the convenience and effectiveness of remote cardiology consultations. Telecardiology offers timely access to expert cardiac care, especially for individuals in remote or underserved areas, enabling early diagnosis, continuous monitoring of chronic conditions, and post-operative follow-ups without the constraints of physical distance. This growth is driven by a combination of factors, including the rising prevalence of cardiovascular diseases, technological advancements, reimbursement support, and the ongoing global shift towards more personalized and accessible healthcare solutions. As the telemedicine landscape evolves, the cardiology specialty is poised to play a pivotal role in shaping the future of remote healthcare delivery.

The web/mobile segment is anticipated to hold a majority of the telemedicine market size throughout the study period.

Based on delivery mode, it is segmented into web/mobile and call centers. The web/mobile delivery mode segment is likely to dominate the market during the forecast timeframe. the growth of web and mobile delivery modes, reflecting the increasing preference for remote healthcare services. This trend is driven by the convenience and accessibility offered by these platforms, allowing patients to connect with healthcare professionals seamlessly from the comfort of their homes. The proliferation of smartphones, coupled with advanced web-based applications, has facilitated real-time consultations, remote monitoring, and prescription delivery, thus expanding the reach of healthcare services to a wider population. As technology continues to evolve and user-friendly interfaces become more prevalent, the web and mobile delivery segment is poised to continue its upward trajectory, reshaping the way healthcare is accessed and delivered.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the Ventilators market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific, is anticipated to be the fastest-growing regional market during the forecast period. This rapid growth can be attributed to the presence of a large patient population pool, increasing internet usage, and rapid demand for healthcare assistance, especially in the rural areas. Emerging economies including India and China are estimated to lead the regional market in the years to come. In March 2021, India Brand Equity Foundation (IBEF) reported that the Indian government launched a telemedicine service-eSanjeevani and completed around 3 million consultations across the nation.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10073/

Competitive Landscape

The global telemedicine market report includes players such as Koninklijke Philips (Netherlands), Medtronic (Ireland), GE Healthcare (US), Cerner Corporation (US), Siemens Healthineers (Germany), Cisco Systems (US), Asahi Kasei Corporation (Japan), Teladoc Health (US), American Well (US), and AMC Health (US), among other.

Recent Developments in the Telemedicine Market:

• In April 2022, Bayer announced that it is setting up 27 telemedicine centres in 12 districts across eight states in India over the next two years through Bayer Foundation India.
• In January 2022, SwiftMD, announced the launch of its newly designed website, SwiftMD.com, and telehealth app as part of a brand refresh.
• In December 2021, Mesmerize announced partnership with VSee. This partnership is aimed to provide additional platform for Mesmerize’s advertisers to reach healthcare providers and patients within Mesmerize’s network telehealth solutions to offer remote patient monitoring services. This partnership will deliver best in class telehealth care service offerings.
• In December 2021, AFC Industries acquired AALL AMERICAN Fasteners (AAF). This acquisition helped the firm to develop innovative and high performing healthcare telemedicine equipment.

Telemedicine Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Telemedicine Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Telemedicine Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Telemedicine industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country analysis is also presented in this report.
• Analytical depiction of the Telemedicine Market along with the current trends and future estimations to depict imminent investment pockets. The overall Telemedicine industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Telemedicine Market are also analyzed.

Global Telemedicine Market Segments

By Service

• Tele-consulting
• Tele-monitoring
• Tele-education/training
• Others

By Type

• Telehospital
• Telehome

By Specialty

• Cardiology
• Gynaecology
• Neurology
• Orthopaedics
• Dermatology
• Mental health
• Others

By Delivery Mode

• Web/Mobile
• Call centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players Profiled in the Report

• Koninklijke Philips (Netherlands)
• Medtronic (Ireland)
• GE Healthcare (US)
• Cerner Corporation (US)
• Siemens Healthineers (Germany)
• Cisco Systems (US)
• Asahi Kasei Corporation (Japan)
• Teladoc Health (US)
• American Well (US)
• AMC Health (US)

New York, August 2023: According to a new research study by Global Insight Services (GIS), the global women’s health diagnostics market is expected to grow rapidly over the next 10 years to reach a value of more than the US $49.0 billion by 2032.

The women’s health diagnostic is a diagnostics method including screening, testing and monitoring of various women’s health disorders such as ovarian cancer, breast cancer, menopause, pregnancy and cervical cancer. For the diagnosis of women’s health-related diseases, various types of tests are available including Breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy & ovulation testing, and ovarian cancer testing are all part of the diagnostic process. To avoid complications and improve quality of life, tests for screening and detection of various disorders are required. Health tests are essential for maintaining good health as well as preventing and treating serious diseases.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10385/

Women’s Health Diagnostics Market: Key Trends and Drivers

The growing awareness and prioritization of women’s health issues, coupled with advancements in medical technology. As societies increasingly recognize the importance of gender-specific healthcare, there is a heightened demand for accurate and specialized diagnostics tailored to women’s unique physiological and reproductive needs. Innovations in diagnostic techniques, such as non-invasive prenatal testing, advanced imaging modalities, and personalized genetic screenings, empower healthcare providers to detect and manage conditions like breast cancer, cervical abnormalities, and pregnancy-related complications with higher precision and early intervention. This evolving landscape not only enhances patient outcomes but also fosters collaborations between healthcare stakeholders, leading to the development of novel diagnostic solutions that cater to the distinct healthcare requirements of women, ultimately driving the growth of the Women’s Health Diagnostics Market.

Women’s Health Diagnostics Market: Restraints & Challenges

IThe growth of the Women’s Health Diagnostics Market may encounter limitations due to the significant costs associated with diagnostic procedures and the relatively low awareness among women about the importance of such procedures. The high financial burden of diagnostic tests could dissuade many women from seeking timely and necessary screenings, thereby impeding early detection and intervention for various health conditions specific to women. Additionally, the lack of awareness regarding the significance of diagnostic procedures may result in a delayed response to potential health issues, hindering the market’s expansion. Addressing these challenges through targeted awareness campaigns, improved accessibility to affordable diagnostics, and enhanced education about women’s health could play a pivotal role in overcoming these constraints and fostering the growth of the market..

Women’s Health Diagnostics Market Report Findings

https://www.globalinsightservices.com/reports/womens-health-diagnostics-market/

Diagnostic Device segment is likely to hold a dominant women’s health diagnostics market share and grow at a substantial CAGR during the forecast period.

Based on type, it is segmented into the diagnostic devices, diagnostic tests, accessories and consumables. In 2022, the diagnostics devices segment was the significant revenue generator and it is anticipated to grow at the fastest growth rate during the forecast period. This is driven by advancing technology and increasing awareness of gender-specific healthcare needs. These devices, ranging from ultrasound systems tailored for obstetric and gynecologic imaging to sophisticated mammography equipment, have gained prominence due to their pivotal role in early detection and accurate diagnosis of various women’s health conditions, including breast cancer, cervical abnormalities, and reproductive disorders. As medical innovations continue to enhance the precision and accessibility of these devices, coupled with rising efforts to prioritize women’s health, the diagnostics devices segment is poised to further expand, ensuring improved healthcare outcomes for women worldwide.

The breast cancer segment is anticipated to hold a majority of the women’s health diagnostics market size throughout the study period.

Based on application, it is segmented into breast cancer, infectious disease testing, osteoporosis testing, pregnancy and fertility testing, sexually transmitted disease testing, other applications. The breast cancer segment is likely to dominate the market during the forecast period. The largest share of the breast cancer is the most commonly occurring cancer in women and the second most common cancer worldwide. According to Globocan 2020, there were around 2,261,419 new breast cancer cases in 2020. The increasing cases resulted in increased sales of test kits for home usage, which is also expected to drive the market’s revenue growth over the forecast period. The rise in the adoption of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging devices worldwide are expected to fuel the market growth.

The homecare settings segment is anticipated to hold a majority of the women’s health diagnostics market size throughout the study period.

Based on end-use, it is segmented into hospitals and clinics, diagnostic and imaging centers, homecare, others. The home care settings segment is expected to witness the highest growth during the forecast period. This expansion can be attributed to several factors, including increasing awareness among women about the importance of regular health check-ups, the convenience and comfort associated with receiving diagnostic services within the familiar setting of their homes, and the ongoing efforts to enhance patient-centric care. Additionally, the increasing advantages of using self-testing kits will continue to drive market growth. Patient self-testing enables patients to better manage their diseases by utilizing home/self-testing kits. Moreover, the COVID-19 pandemic further accelerated the adoption of home-based diagnostics, as many women sought safer alternatives to traditional healthcare facilities. Technological innovations such as portable ultrasound devices, at-home hormone level testing kits, and telemedicine platforms have empowered women to actively engage in monitoring their health, contributing to the growth of the homecare segment. As the healthcare landscape continues to evolve, the homecare segment is poised to play a pivotal role in the Women’s Health Diagnostics Market by providing personalized and accessible diagnostic solutions that cater to the unique needs of women, ultimately improving overall healthcare outcomes and quality of life.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the women’s health diagnostics market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is accounted for the majority of market share during the forecast period. The largest share of the region is primarily attributed to the favorable reimbursement policies for imaging procedures in the US, increased prevalence of cancer, and high investment by hospitals to purchase advanced diagnostics systems. Furthermore, increased research and development efforts have yielded innovative diagnostic tools tailored to women’s unique physiological needs, enabling more accurate and personalized assessments. The region’s robust healthcare infrastructure, coupled with substantial investments in healthcare research and development, has paved the way for the integration of cutting-edge technologies such as molecular diagnostics, advanced imaging modalities, and precision medicine approaches. As a result, the North American Women’s Health Diagnostics Market is witnessing substantial expansion, not only in terms of revenue but also in its ability to provide early detection and effective management of conditions such as breast cancer, cervical abnormalities, and hormonal imbalances, ultimately contributing to improved healthcare outcomes and enhanced quality of life for women across the continent.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10385/

Competitive Landscape

The global women’s health diagnostics market report includes players such as Abbott (U.S.), BD (U.S.), Cardinal Health, Inc. (U.S.), F.Hoffmann-La Roche Ltd. (Switzerland), General Electric Company (U.S.), Hologic, Inc. (U.S.), Koninklijke Philips N.V. (Netherland), Quest Diagnostics Incorporated (U.S.), Siemens Medical Solutions USA, Inc. (Germany), and bioMérieux SA. (U.S.)

In addition, major vendors are focused on developing smarter technologies and devices for cancer and other disease diagnostics. For instance, in January 2021, Roche launched its CE-IVD approved automated digital pathology algorithms, uPath HER2 (4B5) image analysis and uPath HER2 Dual ISH image analysis for breast cancer. This launch was anticipated to expand its customer base and market share.

Recent Developments in the Women’s Health Diagnostics Market:

• In September 2021, Abbott acquired Walk Vascular LLC, a commercial-stage medical device firm with a minimally invasive mechanical aspiration thrombectomy system for the removal of peripheral blood clots.
• In April 2021, Carestream Health entered a partnership with Ziehm Imaging to provide Ziehm Vision RFD C-arm, a surgical imaging system included in the company’s mobile and fluoroscopic product offerings for ensuring exceptional image quality and reducing exposure significantly.
• In July 2019, Paragon Biosciences LLC launched Qlarity Imaging LLC, which was founded to harness the value of artificial intelligence (AI) to improve medical outcomes.
• In June 2019, Genomic Health’s Oncotype DX Breast Recurrence Score test was approved by the German Federal Joint Committee for nationwide reimbursement.

Women’s Health Diagnostics Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Women’s Health Diagnostics Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Women’s Health Diagnostics Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Women’s Health Diagnostics industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Women’s Health Diagnostics Market along with the current trends and future estimations to depict imminent investment pockets. The overall Women’s Health Diagnostics industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Women’s Health Diagnostics Market are also analyzed.

Global Women’s Health Diagnostics Market Segments

By Type

• Diagnostic Devices
• Diagnostic Tests
• Accessories and Consumables

By Application

• Breast Cancer
• Infectious Disease Testing
• Osteoporosis Testing
• Pregnancy and Fertility Testing
• Sexually Transmitted Disease Testing
• Other Applications

By End-use

• Hospitals and Clinics
• Diagnostic and Imaging Centers
• Homecare
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players Profiled in the Report

• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health, Inc. (U.S.)
• F.Hoffmann-La Roche Ltd. (Switzerland)
• General Electric Company (U.S.)
• Hologic, Inc. (U.S.)
• Koninklijke Philips N.V. (Netherland)
• Quest Diagnostics Incorporated (U.S.)
• Siemens Medical Solutions USA, Inc. (Germany)
• bioMérieux SA. (U.S.)

Smart Pills Market to Reach USD 14.3 billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Smart Pills market is expected to grow rapidly over the next 10 years to reach a value of more than USD 14.3 billion by 2032.

Small digital devices known as “smart pills” have a capsule-like shape and are supposed to conduct very complex tasks like sensing, imaging, and medicine administration. When swallowed, these capsules—which may contain a biosensor, an image sensor, a pH sensor, or a chemical sensor—travel along the gastrointestinal track to collect images that would be otherwise challenging to obtain. Additionally, smart pills come with a tiny wearable sensor patch that is linked to a provider portal and an app on a mobile device. These non-invasive tools have transformed how cancer and gastrointestinal problems are diagnosed and can take the place of more traditional diagnostic methods like endoscopy.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10448/      

Smart Pills Market: Key Trends and Drivers

One significant driver for the smart pills market is the growing demand for non-invasive and efficient drug delivery methods. Traditional oral drug administration often faces challenges, such as low patient compliance and inadequate absorption rates, which can affect treatment efficacy. Smart pills, equipped with innovative technologies like sensors and microprocessors, enable remote monitoring of medication intake, ensuring patients adhere to their prescribed regimens. Moreover, these pills can target specific areas within the body, releasing drugs at optimal locations for better absorption, thereby enhancing treatment outcomes. As healthcare providers and patients increasingly seek convenient and personalized healthcare solutions, the demand for smart pills is expected to rise, driving the growth of the smart pills market in the coming years.

Smart Pills Market: Restraints and Challenges

The rising concern over data privacy and security will restraint the smart pills market. Smart pills often utilize advanced technologies to track and transmit data, such as internal body conditions, medication adherence, and other vital health information. This real-time data collection raises apprehensions among consumers and healthcare professionals about potential breaches, unauthorized access, or misuse of sensitive medical data. Ensuring robust encryption, strict regulatory compliance, and implementing foolproof security measures are critical to address these concerns and gain trust in smart pill adoption. Failure to address these privacy and security issues adequately could hinder the widespread acceptance and adoption of smart pills, limiting their potential to revolutionize healthcare and patient monitoring.

Smart Pills Market Report Findings

https://www.globalinsightservices.com/reports/smart-pills-market/

The capsule endoscopy segment is anticipated to dominate the market during the forecast period

Based on the application, it is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is anticipated to dominate the market during the forecast period. Capsule endoscopy, a non-invasive medical imaging technology that utilizes miniature wireless cameras embedded in ingestible capsules, enables physicians to visualize the gastrointestinal tract in unprecedented detail. This innovative approach has gained substantial traction due to its patient-friendly nature, eliminating the need for traditional endoscopic procedures that can be uncomfortable and invasive. With increasing prevalence of gastrointestinal disorders and rising demand for minimally invasive diagnostic techniques, capsule endoscopy is poised to experience substantial growth in the smart pills market, offering promising prospects for improved patient care and medical advancements in this domain.

The esophagus segment is anticipated to dominate the market during the forecast period

Based on the target area, it is segmented into the esophagus, small intestine, large intestine, and stomach. The esophagus segment is anticipated to dominate the market during the forecast period. Smart pills, equipped with cutting-edge sensor and imaging technologies, have shown great potential in revolutionizing the diagnosis and treatment of esophageal disorders, enabling healthcare professionals to obtain real-time insights into the patient’s gastrointestinal health. These smart pills can precisely target the esophagus, monitoring and detecting abnormalities, such as growths and lesions, with unprecedented accuracy and minimal invasiveness. As the global healthcare industry continues to prioritize early detection and personalized treatment options, the rising adoption of smart pills for esophageal target area segment growth holds promise in enhancing patient outcomes, streamlining medical procedures, and ultimately contributing to improved overall healthcare management.

The esophageal diseases segment is anticipated to dominate the market during the forecast period

Based on the disease indication, it is segmented into esophageal diseases, small bowel diseases, colon diseases, and others. The smart pills market is witnessing significant growth in the small bowel diseases segment due to the rising prevalence of gastrointestinal disorders and advancements in medical technology. Smart pills equipped with advanced sensors and wireless communication capabilities offer a non-invasive and real-time monitoring solution for small bowel diseases, providing valuable insights into the patient’s digestive health. These smart pills can detect abnormalities, inflammation, and other gastrointestinal conditions in the small bowel, facilitating early diagnosis and timely intervention. Additionally, the increasing adoption of smart pills by healthcare providers to improve patient outcomes and reduce the need for invasive procedures further propels the market growth in the small bowel diseases segment. As a result, the integration of smart pills into the management of small bowel diseases is anticipated to drive substantial market expansion in the coming years.

The hospital end user segment is anticipated to dominate the market during the forecast period

Based on the end user, it is segmented into hospitals, diagnostic centers, and research institutes. The hospital segment in the smart pills market has witnessed remarkable growth over recent years, fueled by the increasing adoption of advanced healthcare technologies and the rising prevalence of chronic diseases worldwide. Smart pills offer significant advantages in monitoring patient health, enabling real-time data collection, and improving diagnostic accuracy. Hospitals are increasingly embracing these innovative ingestible devices to enhance patient care, track medication adherence, and optimize treatment outcomes. Additionally, the integration of smart pill technologies into hospital settings has streamlined healthcare workflows, leading to improved patient management and operational efficiencies. With the continuous advancements in smart pill technology and a growing focus on patient-centric healthcare, the hospital segment is poised to experience further expansion, revolutionizing the way medical professionals diagnose and treat patients.

The North American region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. This is driven by advancements in healthcare technologies and an increasing emphasis on non-invasive and remote patient monitoring solutions. The region’s well-established healthcare infrastructure, coupled with a rising prevalence of chronic diseases and a growing elderly population, has further accelerated the adoption of smart pills as a promising diagnostic and therapeutic tool. Additionally, favorable government initiatives supporting digital health technologies and the presence of key market players investing in research and development have contributed to the region’s substantial expansion in the smart pills market. With a growing awareness among healthcare professionals and patients about the benefits of smart pills, North America continues to lead in this innovative sector, poised for continued growth and transformative impact on patient care and medical practices.

Moreover, medical researchers ongoing progress in the area of ingestible electronics is what is fueling this growth. The U.S. FDA and other regional agencies have been developing standards for obtaining approvals for digital smart tablets. Over the anticipated period, such actions are anticipated to fuel regional growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10448/

Competitive Landscape

The key players studied in the report are Olympus Corporation, Proteus Digital Health Inc., CapsoVision Inc., MEDTRONIC, FUJIFILM Holdings Corporation, RF Co. Ltd., Check-Cap, BDD Limited, JINSHAN Science & Technology, and MEDISAFE among others.

Recent Developments

• In January 2021, etectRx, Inc., entered into a partnership agreement with Pear Therapeutics, Inc., for the development of two product candidate in the CNS space integrating adherence sensors and PDTs. The partnership is the first of its kind in exploring the usage of digital pill solutions with PDTs.
• In January 2019, Proteus Digital Health launched its first digital cancer chemotherapy pill in the market with an aim to help oncologists track treatment effectiveness and adherence in the cancer patient.
• In October 2018, Proteus Digital Health expanded its partnership with Otsuka Pharmaceutical in order to continue the development and commercialization of its ingestible sensor pill platform.
• In September 2017, Capso Vision Inc., announced the U.S. launch of Capso Cloud, a managing system that allowed physicians to extract data from the Capso Cam Plus smart pill eliminating the need to process capsule post-ingestion.

Smart Pills Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Smart Pills market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Smart Pills market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Smart Pills market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Smart Pills industry.

Global Smart Pills Market Segmentation

By Application

• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By Disease Indication

• Esophageal Diseases
• Small Bowel Diseases
• Colon Diseases
• Others

By End User

• Hospital
• Diagnostic Center
• Research Institute

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Olympus Corporation
• Proteus Digital Health Inc.
• CapsoVision Inc.
• MEDTRONIC
• FUJIFILM Holdings Corporation
• RF Co. Ltd.
• Check-Cap
• BDD Limited
• JINSHAN Science & Technology
• MEDISAFE

Oscillating Positive Expiratory Pressure Devices Market to reach US$ 208.9 Mn by 2032, driven by increasing prevelance of COPD in emerging countries: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Oscillating Positive Expiratory Pressure Devices market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 208.9 Mn by 2032.

The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs’ walls.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10444/

Oscillating Positive Expiratory Pressure Devices Market: Key Trends and Drivers

The increasing prevalence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has led to a surge in demand for mucous clearing devices, with oscillating positive expiratory pressure (OPEP) devices spearheading the growth of the market. These conditions often result in the accumulation of thick mucus in the airways, leading to breathing difficulties and decreased lung function. OPEP devices offer an effective solution by generating oscillations during exhalation, which helps to mobilize and loosen the mucus, facilitating its removal and improving airway clearance. As awareness of the benefits of these devices continues to spread among healthcare professionals and patients alike, the OPEP devices market is poised to experience significant expansion to meet the rising needs of individuals seeking better management of cystic fibrosis and COPD.

Oscillating Positive Expiratory Pressure Devices Market: Restraints & Challenges

The oscillating positive expiratory pressure (OPEP) devices market is facing challenges in its growth trajectory, primarily due to two key factors: low awareness and high cost. Despite the potential benefits these devices offer in improving respiratory health, there remains a lack of sufficient awareness among healthcare professionals and patients alike. This limited awareness hampers the adoption of OPEP devices, as potential users may not fully understand their advantages. Moreover, the relatively high cost associated with these devices also acts as a significant restraint on market growth, making them less accessible to a broader population. To overcome these obstacles, concerted efforts are required from manufacturers and healthcare stakeholders to increase awareness through educational initiatives, while also exploring avenues to make these devices more cost-effective and affordable to a consumers.

Oscillating Positive Expiratory Pressure Devices Market Report Findings

https://www.globalinsightservices.com/reports/oscillating-positive-expiratory-pressure-devices-market/

The mouthpiece PEP device segment is likely to hold a dominant Oscillating Positive Expiratory Pressure Devices market share and grow at a substantial CAGR during the forecast period.

Based on the product type, it is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment is anticipated to dominate the market during the forecast period. These innovative devices have garnered widespread attention and adoption among patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The mouthpiece PEP devices offer several advantages, including enhanced portability, ease of use, and improved patient compliance compared to traditional mask-based PEP devices. Moreover, their ability to effectively mobilize mucus, improve lung function, and reduce the risk of respiratory infections has further fueled their popularity. As healthcare providers and patients increasingly recognize the benefits of mouthpiece PEP devices, their rising demand is expected to drive remarkable growth in the oscillating PEP devices market, ultimately revolutionizing respiratory care and management for those in need.

The COPD & Asthma segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.

Based on the indication, it is segmented into COPD & asthma, bronchitis, cystic fibrosis, and others. The COPD & Asthma segment is anticipated to dominate the market during the forecast period. Due to the primary reason of tobacco use, COPD is brought on by airway blockage that makes breathing difficult. The third leading cause of death worldwide in 2019 is a chronic obstructive pulmonary disease, according to a report from the World Health Organization. Over the projected period, the segment’s growth is anticipated to be boosted by increasing patient awareness of the need to create a unified platform for COPD sufferers. For instance, worldwide, November is recognized as National COPD Month. The COPD (chronic obstructive pulmonary disease) Foundation teams up with a number of respiratory healthcare organizations to organize a number of online and offline events for COPD community members to increase exposure. heance, all such factor will fuel the segment as well as market growth.

The hospitals & clinics segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.

Based on end user, it is segmented into hospital & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to dominate the market during the forecast period. Hospital oscillating positive expiratory pressure (OPEP) devices are expected to be more in demand as a result of the increase of hospitals, especially in developed countries. Furthermore, the segment’s growth is supported by the presence of a well-developed infrastructure and the availability of cutting-edge equipment. Additionally, as more patients are admitted to hospitals, these devices are used more frequently, which boosts revenue in hospital pharmacies.

Moreover, increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis has led to a rise in the demand for effective airway clearance devices in medical settings. OPEP devices have gained popularity in hospitals and clinics due to their ability to help patients clear mucus from their airways, improve lung function, and reduce the risk of exacerbations. Additionally, advancements in technology and the introduction of portable and user-friendly OPEP devices have further fueled their adoption in healthcare facilities. As a result, the hospital and clinics segment is expected to continue experiencing positive growth as healthcare providers recognize the importance of these devices in enhancing respiratory care and patient outcomes.

The Asia Pacific region is estimated to exhibit the highest growth rate during the Oscillating Positive Expiratory Pressure Devices market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Asthma affects 1 in 13 persons, according to a 2019 report from the Centers for Disease Control and Prevention (CDC). Asthma affects more than 25 million Americans. This represents 8.4% of kids and 7.7% of adults. All age, sex, and racial groups have shown an increase in asthma cases since the early 1980s. The American Academy of Allergy, Asthma and Immunology (AAAI) estimates that in 2016, 8.3% of American children were diagnosed with asthma. Boys had an overall higher prevalence of asthma than girls, with rates of 9.2% and 7.4%, respectively. Children’s asthma incidence rose from 8.7% in 2001 to 9.4% in 2010, then fell to 8.3% in 2016. Though not all adjustments were statistically significant. Thus, aforementioned factors will drive the market growth in North America during the forecast period.

Moreover, OPEP devices are increasingly recognized as effective respiratory therapy tools for patients with various pulmonary conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The rising prevalence of respiratory disorders, coupled with the growing geriatric population, has fueled the demand for these devices in the region. Additionally, advancements in technology, leading to the development of more user-friendly and portable OPEP devices, have further driven market adoption. Moreover, an increasing focus on home-based healthcare solutions and a growing emphasis on preventive care are likely to bolster the market’s expansion. As a result, key market players are investing in research and development activities to innovate and launch new OPEP devices, thereby contributing to the market’s growth in North America.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10444/

Competitive Landscape

The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

Recent Developments in the Oscillating Positive Expiratory Pressure Devices Market:

• In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
• In May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ desire to drive process efficiencies and value driven healthcare spending.
• In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
• In February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk.

Oscillating Positive Expiratory Pressure Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Oscillating Positive Expiratory Pressure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Oscillating Positive Expiratory Pressure Devices Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Oscillating Positive Expiratory Pressure Devices industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Oscillating Positive Expiratory Pressure Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall Oscillating Positive Expiratory Pressure Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Oscillating Positive Expiratory Pressure Devices Market are also analyzed.

Global Oscillating Positive Expiratory Pressure Devices Market Segmentation

By Product Type

• Face Mask PEP Devices
• Mouthpiece PEP Devices
• Bottle PEP Devices

By Indication

• COPD & Asthma
• Bronchitis
• Cystic Fibrosis
• Others

By End User

• Hospital & Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• AirPhysio
• Allergan plc.
• D-R Burton Healthcare
• Medica Holdings, LLC.
• Monaghan Medical Corporation
• PARI GmbH
• R. Cegla GmbH & Co. KG
• Smiths Medical, Inc.
• WyMedical Pty Ltd
• Smiths Medical, Inc.

Hearing Aids Market to Reach USD 15.6 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global hearing aids market is expected to grow rapidly over the next 10 years to reach a value of more than USD 15.6 billion by 2032.

A hearing aid is an electronic device made to improve hearing in people who have hearing loss or damaged auditory nerves. Hearing device use is anticipated to increase with the rising prevalence of hearing loss. For instance, 1.1 billion young people (aged 12-35) are at risk of hearing loss as a result of exposure to noise in recreational contexts, according to 2020 WHO publications on deafness and hearing loss.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10291/

Hearing Aids Market: Key Trends and Drivers

It is vital to monitor and analyze hearing functions due to the increased prevalence of hearing loss in the world. Untreated hearing loss in children has a detrimental influence on social interaction, learning, and language development. Similar to younger folks, older adults with hearing loss frequently struggle to follow daily conversations. Untreated hearing loss has been associated with a number of medical and mental problems in older adults, including depression and cognitive decline as well as a higher risk of trips and falls. Likewise, Major market participants have significant growth prospects in emerging economies like South Korea, Malaysia, Vietnam, South Korea, Africa, Israel, Saudi Arabia, and the United Arab Emirates. This is due to factors such as their lax regulatory requirements, improved healthcare facilities, expanding patient populations, and rising healthcare costs. Additionally, compared to industrialized nations, the regulatory regulations in the Asia-Pacific area are more flexible and business-friendly. This has led major companies in the hearing aids industry to concentrate on growing nations, along with the escalating competition in mature areas.

Hearing Aids Market: Restraints and Challenges

A significant factor limiting market growth is the high cost of hearing aids, including cochlear implants and bone-anchored systems, particularly in price-sensitive regions like the Asia Pacific, Latin America, and Africa. Healthcare providers generally lack the financial resources to invest in sophisticated technologies, particularly in developing nations like Brazil and Mexico. Additionally, the staff must receive comprehensive training in the proper handling and upkeep of bone-anchored devices and cochlear implants. Technology-advanced hearing aids must be developed through extensive R&D efforts. As a result, both the manufacturing cost and the final price for clients increase significantly. As a result, patients must pay a proportionally high price for the related surgical interventional treatments and diagnostic testing.

Hearing Aids Market Report Findings

https://www.globalinsightservices.com/reports/hearing-aids-market/

The behind-the-ear segment accounted for the largest revenue share of the market during the forecast period

Based on product type, it is segmented into in-the-ear, receiver-in-the-ear, behind-the-ear, and canal. The behind-the-ear segment accounted for the largest revenue share of the market during the forecast period. BTE hearing aids are made up of a compact, curved housing that fits behind the ear with ease. By attaching them to external sound sources like infrared listening devices and auditory training apparatus, these goods can be modified. Different BTE versions support Bluetooth, which improves wireless connectivity and drives the market. Because they have a powerful amplifier and a large battery, these gadgets also have a stronger sound amplification. Additionally, behind-the-ear (BTE) devices can fit into a variety of ear molds, are simple to use and clean, and are more popular among younger people. Additionally, they don’t need to be replaced as the youngster gets older. With the development of new technologies, smaller, more comfortable devices like the Mini BTE are created. Various elements have contributed to the market expansion of these BTE products.

Digital devices segment dominated the market during the forecast period

Based on technology, it is segmented into analog, and digital. Digital devices segment dominated the market during the forecast period. With a slower growth rate than their digital counterparts, analog gadgets are close to being outdated. Despite this, producers still make analog hearing aids due to their low cost and a small number of consumers’ resistance to switching to digital ones. On the principle of amplifying continuous sound waves, analog devices operate. In these goods, all sounds, including speech and noise, are amplified uniformly. Due to the presence of an inbuilt microchip that enables the programming of various settings for various listening conditions, a few analog devices are programmable.

The retail segment dominated the market during the forecast period

Based on sales channel, it is segmented into retail sales, government purchases, and E-commerce. The retail segment dominated the market during the forecast period. One of the key drivers of a significant portion of retail sales is the availability of over-the-counter hearing aids. Over the projected period, e-commerce and government purchases of these gadgets are anticipated to expand at a profitable rate. A huge number of retail establishments, an increase in manufacturing companies entering the retail sales market, and a high sales margin are all factors that have contributed to the retail sales segment’s rise. These products retail sales are further divided into company-owned and independent retail outlets. Due to the market’s low barriers to entry for new retailers, strong profit margins, and extensive consumer interaction, independent retail stores predominated.

The Europe region dominated the market during the forecast period

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Europe dominated the market with a significant revenue share in 2022.  An increase in the prevalence of auditory loss and a rise in awareness regarding technological advancements are the major factors driving the demand for these devices in Europe. In addition, the growth of the audiology devices market in this region depends on the reimbursement policies of each European nation. According to the WHO’s 2021 report about Hearing, 196 million people in the WHO area of Europe had some hearing impairment, with 57.3 million (6.2%) having a severe or higher degree of hearing impairment.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10291/

Competitive Landscape

The key players studied in the market are Sonova Group, Demant A/S, GN Store Nord A/S, Cochlear Ltd., RION Co., Ltd., Starkey, Nurotron Biotechnology Co., Ltd., MED-EL, Audina Hearing Instruments, Inc., Elkon Pvt. Ltd., WS Audiology A/S, Eargo, Inc. and Horentek among others.

Recent Developments

• September 2021, Audientes, a company offering lower cost hearing aids to low-income countries, entered into a partnership with Hearing Wellness Clinic, a chain of hearing centers in South India, to introduce its self-adjusting hearing aids to the Indian market.
• August 2021, Phonak launched Audeo Life, the world’s first waterproof rechargeable hearing aid.
• May 2021, Bose entered into the over-the-counter hearing aids category by selling sound-controlled hearing aids directly to patients who suffer from mild to moderate hearing loss.
• February 2021, GN Hearing launched Re Sound Key, a hearing aid line-up that provides greater access to its proven and award-winning hearing technology across the globe.
• October 2020, Starkey partnered with Or Cam Technologies to provide assistive technologies to hearing and visually impaired people. This partnership enhanced or Cam’s ability to apply the advanced computer vision and machine learning methods that they had developed to transmit the visual world through audio, in collaboration with Starkey’s Livio Edge AI hearing aids.
• July 2020, Cochlear Ltd. Received US FDA approval for its Cochlear Nucleus Kanso 2 Sound Processor, Nucleus 7 Sound Processor for Nucleus 22 Implant recipients, and custom Sound Pro fitting software.

Hearing Aids Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Hearing Aids Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Hearing Aids Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hearing Aids Industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Hearing Aids Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hearing Aids industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hearing Aids Market are also analyzed.

Global Hearing Aids Market Segmentation

By Product Type

• In-the-Ear
• Receiver in-the-Ear
• Behind-the-Ear
• Canal

By Technology Type

• Analog
• Digital

By Sales Channel

• Retail Sales
• Government Purchases
• E-commerce

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Sonova Group
• Demant A/S
• GN Store Nord A/S
• Cochlear Ltd.
• RION Co., Ltd.
• Starkey
• Nurotron Biotechnology Co., Ltd.
• MED-EL
• Audina Hearing Instruments, Inc.
• Elkon Pvt. Ltd.
• WS Audiology A/S
• Eargo, Inc.
• Horentek

Hospital Acquired Infection Control Market to Reach USD 26.8 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global hospital-acquired infection control market is expected to grow rapidly over the next 10 years to reach a value of more than USD 26.8 billion by 2032.

Nosocomially acquired illnesses that are not present or incubating at the time of admission to a hospital are known as hospital-acquired infections (HAIs). These infections include bloodstream infections linked to central lines, urinary tract infections linked to catheters, surgical site infections, pneumonia linked to ventilators, pneumonia acquired in hospitals, and infections with Clostridium difficile. A productive cough, shortness of breath, abdominal discomfort, rebound tenderness, altered mental status, palpitations, suprapubic pain, polyuria, dysuria, and costovertebral angle tenderness are signs that an infection is present.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10297/

Hospital Acquired Infection Control Market: Key Trends and Drivers

Some of the major factors driving this market are rising awareness about Hospital Acquired Infections (HAIs), the need to prevent cross-infections, the incidence of infectious diseases in healthcare facilities, and supportive government programs to encourage infection control techniques. The development of national, regional, and hospital-level infection prevention guidelines and policies as well as the expanding use of monitoring tools are both contributing to the expansion. Similarly, the market for hospital-acquired infection control is anticipated to grow as a result of factors including the increased demand for sterilization and disinfection in hospitals and clinics, technological developments in sterilization and disinfection equipment, an increase in hospitals outsourcing sterilization services to pharmaceutical and medical device companies, and an increase in the production of medical nonwovens and single-use products due to an increase in COVID-19 cases.

Hospital Acquired Infection Control Market: Restraints and Challenges

The market for hospital acquired infection control is predicted to rise, but this expansion is expected to be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed instruments. In contrast, it is anticipated that the growing use of single-use medical nonwovens and devices would present profitable prospects during the projection period.

Hospital Acquired Infection Control Market Report Findings

https://www.globalinsightservices.com/reports/hospital-acquired-infection-control-market/

The protective barrier segment is anticipated to dominate the market during the forecast period

Based on the product & services, it is segmented into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. The protective barrier segment is anticipated to dominate the market during the forecast period. This is attributed to an increase in the general public’s awareness of personal hygiene, an increase in surgical procedures, a rise in the use of medical nonwovens, such as face masks, surgical drapes, and gowns, as a result of an increase in COVID-19 cases, and an increase in the manufacturing of gloves and nonwoven products.

The hospital-acquired pneumonia segment is expected to dominate the market during the forecast period

Based on the infection type, it is segmented into hospital-acquired pneumonia, bloodstream infections, surgical site infection, gastrointestinal infections, urinary tract infections, and others. The hospital-acquired pneumonia segment is expected to dominate the market during the forecast period. Some of the major factors driving this market include rising awareness regarding Hospital Acquired Infections (HAIs), the requirement to prevent cross-infections, the prevalence of infectious diseases in healthcare facilities, and encouraging government initiatives to promote infection control practices.

The hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market

Based on the end user, it is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is the major shareholder in the hospital-acquired infection control market. Due to an increase in the number of surgical procedures performed in hospitals, an increase in the prevalence of hospital-acquired infections, an increase in the number of hospitals and clinics, and an increase in the number of elderly people, who also have an increase in the prevalence of chronic illnesses.

North America dominated the market and accounted for the largest revenue share in 2022

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market and accounted for the largest revenue share in 2021. The presence of important companies, the initiatives they launched in the public and private sectors, and the rising awareness of HAIs in this area are all factors that contribute to the big share. For instance, the American-based Ecolab purchased the Swiss company vanBaerle Hygiene AG in December 2020. This expanded the product portfolio and service capabilities of Ecolab by providing a broad spectrum of cleaning, disinfection, and hygiene solutions. The CDC is in charge of epidemic investigations, surveillance, research, and HAI prevention in the United States. In accordance with the HHS Action Plan to Avoid Healthcare-Associated Infections in Acute Care Hospitals, the CDC also develops novel methods to prevent infections related to healthcare. In the upcoming years, it is anticipated that supportive measures like these will fuel regional growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10297/

Competitive Landscape

The key players analyzed in the market are Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, and Bayer AG among others.

Recent Development

• September 2021, Sodexo has expanded its partnership with Ecolab in the United States for the control of hospital-acquired infections through the Protecta Plus programme. This programme was created to reduce infection risk in hospitals and healthcare facilities by utilizing Ecolab’s Bioquell hydrogen peroxide vapor technology.
• July 2021, UVision 360 Inc. announced that it had received approval for the expansion of reprocessing procedures for utilization with the Luminelle DTx system.
• April 2020, Allegheny Health Network (AHN), announced a sterilization process that would allow the reuse of N95 masks that were very crucially in demand.
• April 2020, Steris received Emergency Use Authorization (EUA) from the U.S. FDA for respirator decontamination. This allowed the company to temporarily offer a solution for decontamination of compatible N95 or N95-equivalent respirators using STERIS V-PRO Low Temperature Sterilization Systems.

Hospital Acquired Infection Control Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Hospital Acquired Infection Control Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of the Hospital Acquired Infection Control Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Hospital Acquired Infection Control Market industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Hospital Acquired Infection Control Market along with the current trends and future estimations to depict imminent investment pockets. The overall Hospital Acquired Infection Control Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Hospital Acquired Infection Control Market are also analyzed.

Global Hospital Acquired Infection Control Market Segmentation

By Products & Services

• Sterilization
• Cleaning & Disinfection Products
• Protective Barriers
• Endoscope Reprocessing Products

By Infection Type

• Hospital-acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTI)
• Others

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Olympus Corporation
• Medivators Inc. (Cantel Medical Corp.)
• Getinge Group
• STERIS Plc.
• Belimed AG (Metall Zug)
• Steelco S.P.A
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd
• Merck & Co. Inc.
• Advanced Sterilization Products Services Inc. (Johnson & Johnson)
• Abbott Laboratories
• Bayer AG

Powered Wheelchair Market to Reach US$ 6.8 bn by 2032, driven by rapid advancement of flexible endoscope technology: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global powered wheelchair market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 6.8 bn by 2032.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24313/

Powered Wheelchair Market: Key Trends and Drivers

The rise in the older population and the prevalence of chronic diseases are both contributing to the rise in disability that is set to benefit the market. Electrical wheelchairs are thus used in hospitals and healthcare facilities to increase the welfare of patients and healthcare workers. According to figures given by the World Health Organization, the proportion of persons aged 65 and more in the world population will quadruple from 7% in 2000 to 16% by the end of 2050. By that time, the number of elderly persons in the population will outnumber youngsters (aged 0–14 years). The Office of National Statistics of the UK estimated the proportion of people aged 85 and above is set to be double in the next 25 years.

Powered Wheelchair Market: Restraints & Challenges

The powered wheelchair market is expected to be restrained by the lack of reimbursement policies for powered wheelchair across several countries. The powered wheelchair is a class II medical device in the US, which requires a physicians prescription for reimbursement from Medicare. In Europe, the powered wheelchair is classified as a Class I medical device, which allows for reimbursement from national health insurance systems. However, in several countries, there is no specific classification for powered wheelchair, which limits the reimbursement for the device. The powered wheelchair market is also expected to be challenged by the high cost of the device. The powered wheelchair can cost up to $20,000, which is not covered by Medicare or most private insurance plans. In addition, the powered wheelchair requires regular maintenance and upkeep, which can add to the overall cost of ownership.

Powered Wheelchair Market Report Findings

https://www.globalinsightservices.com/reports/powered-wheelchair-market/

The rear wheel segment is likely to hold a dominant powered wheelchair market share and grow at a substantial CAGR during the forecast period.

Based on product, the global powered wheelchair market is segmented into front wheel, mid wheel, rear wheel, and others. The rear wheel segment accounted for significant market share in the year 2022 and is expected to expand at a CAGR of 6.2% over the forecast period. Rear wheel drive (RWD) wheelchair is powered through the engine driving the rear wheels. These wheelchairs provide better control and power in fast corners, and do not lose traction as well. The rear-wheel-drive wheelchair spread the weight evenly as compared to its counterparts. The RWD are sturdy and are resistant to wear and tear. For instance, the Invacare Aviva Storm Rx power wheelchair is a RWD integrated with electronic control system, which can be used for indoor as well outdoor travel. According to the WHO 2021 statistics, more than 1 billion people worldwide are living with some form of disability. The prevalence of disability is vividly increasing due to the changing demographics, and rising burden of chronic diseases. Additionally, around 3.8% of the global population suffer from major difficulties in daily functioning and require assistance. Consequently, the rising burden of disability is set to propel the demand for powered wheelchair thereby fueling the market expansion over the analysis period.

The adult patient segment is anticipated to hold a majority of the powered wheelchair market size throughout the study period.

Based on the category, the powered wheelchair market is divided into adult, and pediatric. The adult patients using electric wheelchair accounted for significant market share in 2022. With the technological advancements in all the sectors over the past few years, the patients also show an increased tendency in accepting innovative products for their healthcare. Electric wheelchair has been in existence for a long time. But, in recent times, healthcare infrastructure has developed to a greater extent, accessibility to modern and quality healthcare, availability of innovative products and increased per capita income have directly affected the demand of these products. According to a research article, approximately three fourth of the geriatric population use the internet and are comfortable using smartphones. Thus, all the aforementioned factors contribute to the high share of adult patients using motorized wheelchair, thereby attributing to the powered wheelchair market development.

The homecare segment is anticipated to hold a majority of the powered wheelchair market size throughout the study period.

The electric wheelchair end-users are segmented into hospitals, homecare, ambulatory surgical centers, and rehabilitation centers. The homecare segment surpassed significant revenue share in 2022. Majority of the patients suffering from chronic conditions are hampering their mobility stay at home. Opting for homecare offers the patients advantages such as increased comfort, personalized care, family involvement, companionship, amongst others. A home care plan is tailored to your family’s needs rather than conforming to the schedules and routines of a care facility. Homecare facility can also be customized based on the patients need for assistance such as few hours, or full-time care. Therefore, owing to the various advantages, homecare segment will propel the industry expansion over the analysis period.

The Asia Pacific region is estimated to exhibit the highest growth rate during the powered wheelchair market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific is projected to be the fastest-growing regional market over the forecast period. The region is backed by a large population base in countries, such as India and China, owing to the improvements in healthcare facilities and growing government initiatives for offering quality mobility devices. Moreover, the high geriatric population in countries, such as Japan, also supports market growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24313/

Competitive Landscape

The global powered wheelchair market report includes players such as Carex Health Brands, Inc., Drive Medical Design & Manufacturing, Graham-Field Health Products, Inc., Invacare, Medline, Sunrise Medical LLC., Karman Healthcare, Quantum Rehab, Numotion Pride, Mobility Products Corp, among Seating Matters among others. In addition, major vendors are focused on developing smarter technologies for surface disinfections.

Recent Developments in the Powered Wheelchair Market:

• In January 2022, Invacare Corp announced the launch of AVIVA STORM RX Narrow Base Power Wheelchair. This wheelchair is innovated to provide extra maneuverability and navigation to its standard counterpart. The addition of this product to their electric wheelchair portfolio helped the company to expand their portfolio as well as improve product penetration amongst diverse end users.
• In December 2021, Meyra Gmbh announced the launch of iChair Meylife, an intelligent power wheelchair. This product was introduced for patients suffering from tetraplegia, traumatic brain injury, paraplegia, Parkinsons disease, leg amputations and many more conditions. This product with its state-of-the-art capabilities will help the company generate revenue streams in the market.
• In July 2021, Sunrise Medical launched the QUICKIE Nitrum ultra-light wheelchair which offers the highest rigidity and strength.
• In January 2020, a U.S.-based startup, Segway, Inc., launched an egg-shaped pod that allows people to sit while they effortlessly cruise around campuses, theme parks, airports, and even cities. This pod can also be used by individuals with wheelchair needs and particularly caters for transportation with a high speed of 24 mph

Powered Wheelchair Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Powered Wheelchair Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of the Powered Wheelchair Market in terms of revenue ($Million).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Powered Wheelchair Market industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Powered Wheelchair Market along with the current trends and future estimations to depict imminent investment pockets. The overall Powered Wheelchair Market Industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Powered Wheelchair Market are also analyzed.

Global Powered Wheelchair Market Segmentation

By Product

• Front Wheel
• Mid Wheel
• Rear Wheel
• Others

By Application

• Adults
• Pediatric

By End-user

• Homecare
• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• Carex Health Brands, Inc.
• Drive Medical Design & Manufacturing
• Graham-Field Health Products, Inc.
• Invacare
• Medline
• Sunrise Medical LLC.
• Karman Healthcare
• Quantum Rehab
• Numotion Pride
• Mobility Products Corp
• Seating Matters

Germany Dental CAD-CAM Market to Reach US$ USD 281.7 Mn by 2032, driven Rising prevalence of dental disorders: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Germany Dental CAD-CAM Market is expected to grow rapidly over the next 10 years to reach a value of more than the USD 281.7 million by 2032.

CAD/CAM dentistry” refers to the software enabling dental practitioners to do complicated restorations more quickly, effectively, and occasionally even more precisely. Professionals conducting complex dental operations benefit from using software programs called computer-aided design (CAD) and computer-aided manufacturing (CAM). Restorations made of high-strength ceramic, such as crowns, inlays, onlays, veneers, bridges, dentures, and implant-supported restorations, are created by dental practices and laboratories using CAD/CAM technology.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24743/

Germany Dental CAD-CAM Market: Key Trends and Drivers

Rising prevalence of dental disorders

The rising incidence of dental infections and other periodontal diseases, the demand for dental care facilities, dental surgical procedures, and dental care staff, as well as technical improvements, all contribute to an increase in these conditions, which are some of the major factors propelling the growth of this market. Moreover, due to the growing aging population, there has been an increase in dental implants and oral surgeries being performed. According to the Germany Federal Statistical Office 2022 report, there are roughly 83.2 million people in Germany. Of these, 16.2 million people are over 67 years old, and this is expected to rise to 21.4 million by 2040. In addition, oral cavities are being impacted by a decline in manual dexterity, an increase in co-morbidity, and medication use. Hence, dental care in aged care facilities is found to be poor, and access to dental professionals is difficult. There are several other risk factors, such as smoking, poor oral hygiene, diabetes, medication, and hereditary conditions, which increase dental diseases.

Germany Dental CAD-CAM Market: Restraints & Challenges

High cost of dental CAD CAM system in Germany

The high cost of dental CAD CAM (Computer-Aided Design/Computer-Aided Manufacturing) systems in Germany is restraints the market growth. For instance, according to an article published by All3DP, the average selling price of a complete CAD/CAM system ranges in between USD 90,000.0 to USD 112,000.0 including cost of scanner, milling machine, and associated software.Dental CAD CAM systems are advanced technological solutions that allow for precise and efficient fabrication of dental prosthetics, such as crowns, bridges, and implants. However, these systems often come with substantial price tags, making them unaffordable for many dental practices, especially smaller ones or those in rural areas. The high initial investment required to purchase and set up a dental CAD CAM system, along with the ongoing maintenance costs, can be prohibitive for dentists and dental laboratories, limiting their ability to adopt this technology.

Moreover, the high cost of dental CAD CAM systems can also impact patients’ access to quality dental care. As dental practices bear the burden of the expensive equipment, they may pass on the costs to patients through higher prices for dental treatments involving CAD CAM restorations. This can make dental services less affordable for individuals, potentially leading to delayed or inadequate treatment, limiting the overall adoption and utilization of these systems in the dental industry.

Germany Dental CAD-CAM Market Report Findings

https://www.globalinsightservices.com/reports/germany-dental-cad-cam-market/

The In-lab Systems segment is likely to hold a dominant Germany Dental CAD-CAM Market share and grow at a substantial CAGR during the forecast period.

By Type, the Dental CAD/CAM market is segmented into In-lab Systems and In-office Systems. The In-lab Systems segment is anticipated to dominate the market during the forecast period. The segment was valued at USD 69.0 Million in 2017, and it is anticipated to grow further to USD 181.0 million by 2032, at a CAGR of 7.7% during the forecast period. Likewise, the In-office Systems segment is likely to witness the fastest growth during the forecast period by growing at a CAGR of 9.5% during the forecast period. The segment was valued at USD 29.6 million in 2017 and it is anticipated to grow further to USD 100.7 Million by 2032. The increasing number of dentists and dentistry offices in Germany is anticipated to enhance the market growth. For instance. In 2019, there were 98,604 registered dentists in Germany, of whom 72,589 were actively practicing. To practice, dentists must be accredited by the National Dental Association of Statutory Health Insurance (Kassenzahnärztliche Bundesvereinigung (KZBV)) and meet strict criteria. In fact, around 400 independent dental practices treat only privately insured patients in the country.

Moreover, the increasing demand for chairside systems will boost product use. Chairside CAD/CAM systems include a scanner and a milling device. The conventional impression is replaced by a digital optical impression, and in most cases, the prosthetic restoration is manufactured on the spot, which is a major time-saving advantage. This system provides unique benefits such as better patient comfort, reduce procedure time along with improved quality. they also offer competitive advantages to dentists by helping them provide digital service at a faster pace. Thus more dentists are adopting in-office or chairside systems, propelling the dental CAD/CAM industry growth in Germany.

The hardware segment is anticipated to hold a majority of the Germany Dental CAD-CAM Market size throughout the study period.

By component, the market is divided into hardware and software. The hardware segment is anticipated to dominate the market during the forecast period. Likewise, the software segment is anticipated to witness the fastest growth during the forecast period.

Hardware includes equipment such as milling machine, intraoral scanners, extra oral scanners, and many others. Rise in demand for intraoral scanners play a significant role as Intraoral scanners are commonly used in dentistry to capture direct optical imprints. To acquire high-speed imprints of teeth, most dentists employ cutting-edge intraoral scanners. Many makers of dental CAD/CAM systems are turning to an open design so that the software may be compatible with any milling device. Intraoral scanners and CAD improvements ensure patient safety while also enhancing patient results. These scanners’ accuracy, speed, and comfort for patients are all improving in order to serve a broader patient populated countries like Germany.

Additionally, the increase in demand for digital dentistry in Germany is one of the reasons to fuel the growth of the market. CAD/CAM technologies enable digital veneering workflow and automate the manufacture and quality standardization of dental restorations. As there are more active cases of dental caries and concerns of oral health can propel market’s growth in German region.

The dental clinics segment is anticipated to hold a majority of the Germany Dental CAD-CAM Market size throughout the study period.

By end-use, the Germany dental CAD-CAM market has been segmented into dental clinics, dental laboratories, and dental milling centers. The dental clinics segment is anticipated to dominate the market during the forecast period. Besides, the dental milling centers segment is likely to witness the fastest growth during the forecast period. Overall, CAD/CAM technology may assist dental clinics in treating patients more effectively, precisely, and affordably while enhancing the patient experience. Due to the excellent accuracy of CAD/CAM technologies, restorations fit better and clinical results are enhanced. Dental clinics may treat patients more quickly by using CAD/CAM technologies, which can drastically reduce the time needed to design and construct restorations. Restorations that are extremely accurate and complicated can be made with CAD/CAM technology, which may not be achievable with conventional methods. CAD/CAM systems can be a cost-effective option for dental clinics by minimizing the need for human labor and several sessions.

The patient experience can be enhanced using CAD/CAM technology to eliminate the requirement for dirty and unpleasant impression materials. With enhanced communication between the dentist clinic made possible by CAD/CAM technology, restoration turnaround times might be sped up. Highly customized restorations that match each patient’s unique demands can be made using CAD/CAM technologies. Therefore, the dental clinics segment has a significant market share.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24743/

Competitive Landscape

The key players in the Germany Dental CAD-CAM Market are Align Technology, Inc. (exocad GmbH), Ardian (imes-icore GmbH), Argen Dental GmbH, CADdent GmbH (DeguDent GmbH), Dentsply Sirona (Sirona Dental Systems, Inc.), INFINIDENT Solutions GmbH, Ivoclar Vivadent, Henry Schein, Inc. (BioHorizons, Inc.), Zimmer Biomet, Zirkonzahn srl., and 3M Company, among others.

Recent Developments in the Germany Dental CAD-CAM Market:

• In December 20222, Mindray introduces new wearable patient monitoring system, refining clinicia’s workflow to track patient conditions. “mWearTM” supports comprehensive and precise measurements of patient status, integrating 6 key vital signs powered by Anti-motion Algorithm, specialized health parameters, status indicators and time analysis. mWearTM features two monitoring modes, Wearable Mode and Continuous Mode, for caregivers to get patient status updates accordingly to the customize setting, and intelligently triggers emergencies and alarm escalations to ensure timely response to patient deterioration.
• In September 2022, Apple introduced Apple Watch Series 8 and the new Apple Watch SE, which bring ground breaking technology and performance, and important safety innovations to the two best-selling smartwatches. The new Apple Watch SE delivers the core Apple Watch experience, including Activity tracking, high and low heart rate notifications, and Emergency SOS, as well as the new Crash Detection feature.
• In August 2022, Medtronic plc announced the completion of its acquisition of Affera, Inc. This purchase broadens the company’s cardiac ablation offering by adding its inaugural cardiac mapping and navigation platform, which includes a distinct, fully integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.

Germany Dental CAD-CAM Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Germany Dental CAD-CAM Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of Germany Dental CAD-CAM Market in terms of revenue ($Million)
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the UK Wearable Cardiac Devices industry.
• A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
• Analytical depiction of the Germany Dental CAD-CAM Market along with the current trends and future estimations to depict imminent investment pockets. The overall UK Wearable Cardiac Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Germany Dental CAD-CAM Market are also analyzed.

Germany Dental CAD-CAM Market Segmentation

By Type

• In-lab Systems
• In-office Systems

By Component

• Hardware
• Software

By End-user

• Dental Clinics
• Dental Laboratories
• Dental Milling Centers

Key Players

• Align Technology, Inc. (exocad GmbH)
• Ardian (imes-icore GmbH)
• Argen Dental GmbH
• CADdent GmbH (DeguDent GmbH)
• Dentsply Sirona (Sirona Dental Systems, Inc.)
• INFINIDENT Solutions GmbH
• Ivoclar Vivadent
• Henry Schein, Inc. (BioHorizons, Inc.)
• Zirkonzahn srl.
• Zimmer Biomet
• 3M Company

UK Wearable Cardiac Devices Market to Reach US$ 3,427.6 M by 2032, driven by growing attention on improving customer engagement process: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global UK Wearable Cardiac Devices Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 3,427.6 million by 2032.

Wearable cardiac devices are intended to assist those with heart rhythm abnormalities in managing irregular heartbeats. The heart’s electrical system, which instructs the heart to contract and circulate blood throughout the body, is the source of these anomalies. Wearable technology is a creative answer to several problems in the healthcare sector. Additionally, employed to manage patients and diseases, wearable technology has the potential to influence clinical judgment significantly. Heart-related information may be calculated, displayed, and stored in real-time using wearable cardiac devices and medical gadgets worn on the body. These items include wristwatches, patches, and fitness trackers.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS24744/

UK Wearable Cardiac Devices Market: Key Trends and Drivers

Rising cases of cardiovascular disorders in the UK

The rising cases of cardiovascular disorders in the UK have indeed been a major concern in recent years. Around 1.2 million people in the UK are registered with atrial fibrillation, with nearly half a million (422,600) predicted to have AF undiagnosed, according to Public Health England. And there are more than 100,000 strokes in the UK each year, causing 38,000 deaths, making it a leading cause of death and disability. These numbers highlight the scale of the problem and the need for effective prevention and management strategies. This alarming trend has put significant pressure on healthcare systems and has led to an increased focus on preventive care and monitoring. In response to this growth need, propelling the demand for wearable cardiac devices in the country.

Several factors contribute to the rising cases of cardiovascular disorders in the UK. One of the key drivers is an aging population. The UK has witnessed a steady increase in the average age of its citizens, and older adults are more susceptible to heart-related problems. Additionally, unhealthy lifestyle choices such as poor diet, lack of physical activity, smoking, and excessive alcohol consumption are major risk factors for cardiovascular diseases. The prevalence of these risk factors in the population, coupled with the high-stress levels of modern life, contribute to the increasing burden of heart diseases.

UK Wearable Cardiac Devices Market: Restraints & Challenges

The high cost associated with wearable cardiac devices

The high cost associated with wearable cardiac devices in the UK is a significant factor restraining the growth of the market. These devices, which include wearable heart monitors, implantable cardioverter-defibrillators (ICDs), and cardiac rhythm management (CRM) devices, often come with a hefty price tag. The cost of development, manufacturing, regulatory compliance, and ongoing support services contribute to the overall expenses associated with these devices. As a result, the high prices pose a financial burden for patients, healthcare providers, and the National Health Service (NHS) in the UK, limiting the adoption and market growth of wearable cardiac devices.

One of the main reasons for the high cost of wearable cardiac devices is the research and development investment required to bring innovative technologies to market. Developing advanced sensors, miniaturized components, and reliable connectivity features involves substantial financial resources. Additionally, ensuring compliance with strict regulatory standards, such as obtaining necessary certifications, further adds to the expenses. The costs associated with clinical trials, testing, and obtaining regulatory approvals also contribute to the high price point of these devices, making them less accessible to a larger population.

UK Wearable Cardiac Devices Market Report Findings

https://www.globalinsightservices.com/reports/uk-wearable-cardiac-devices-market/

The holter monitor segment is likely to hold a dominant UK Wearable Cardiac Devices Market share and grow at a substantial CAGR during the forecast period.

By Device, the UK Wearable Cardiac Devices market is bifurcated into Holter monitors, patches, defibrillators, smartwatches, and others. The Holter Monitors segment is anticipated to grow at a rate of 20.5% during the forecast period. The Holter monitoring electrocardiogram records the heart rhythm for up to a few minutes whereas Holter monitoring records the rhythm for 24 hours. This helps to detect arrhythmias that may only occur at certain times. The growth of the Holter ECG monitoring segment is driven by a rise in the geriatric population, an increase in the prevalence of heart stroke, a surge in the number of patients suffering from hypertension, and an upsurge in the prevalence of obesity. Moreover, technological advancements and growth in awareness about the feasible use of these devices are other factors that contribute to the growth of the market. However, a lack of trained professionals, inappropriate healthcare infrastructure, and unsteady reimbursement policies are expected to hinder market growth. Conversely, advanced Holter monitors with enhanced sensitive algorithms for the automatic detection of arrhythmias offer lucrative growth opportunities for the market.

The home healthcare segment is anticipated to hold a majority of the UK Wearable Cardiac Devices Market size throughout the study period.

Based on Application, the UK Wearable Cardiac Devices market is segmented into home healthcare, remote patient monitoring, sports and fitness, and others. The UK wearable cardiac devices market size for the home healthcare segment grew at a rate of 20.4% from 2023 to 2032. The aging population’s growing desire for at-home healthcare segment will increase demand for wearable cardiac devices in the UK. It is driven mostly by the growing number of older adults with cardiovascular diseases. Additionally, wearable trackers offer effective heart rate monitoring and give users access to real-time data that assists in risk identification and lowers hospital visits. Wearable technology that continuously monitors heart problems at home will result in fewer hospital visits, increasing its popularity throughout the projection period. These technologies, designed to assist patients in their homes, allow people to get healthcare services without traveling to Hospitals or clinics. The home healthcare application includes equipment for respiratory treatment. The increased need for customized healthcare services and the aging population drives the demand for wearable medical equipment. IoT and AI technologies would also hasten the market’s growth for wearable home healthcare devices.

The home care segment is anticipated to hold a majority of the UK Wearable Cardiac Devices Market size throughout the study period.

The home care settings segment held the majority of the market share throughout the study period. Home care may be the answer to having the best quality of life possible. Through treatment provided in the security and comfort of home, it may facilitate safety, security, and enhanced independence; it can simplify the management of a continuing medical condition; it can assist in preventing needless hospitalization; and it can speed up recovery after an illness, accident, or hospital stay. Even when frailty is a problem, in-home care often results in better life satisfaction. Home care aids and preserves family unity. Families typically take a more active role in providing care and fostering close relationships with their loved ones. Home care professionals have developed effective models for illness management, medication management, behavioral education, and care coordination in recent years. They have set the bar for creative and economic applications of treatments and technology to provide high-quality, client-centered care throughout the healthcare delivery system.

The England country is estimated to exhibit the highest growth rate during the UK Wearable Cardiac Devices Market forecast period.

The wearable cardiac devices market in England is anticipated to grow at a CAGR of 19.0% from 2023 to 2032.. The number of CVD, CHD, Stroke, heart failure, atrial fibrillation, and other conditions of the heart patients in England is substantial. In accordance with the British Heart Foundation (BHF), there are over 7 million individuals living with CVD, and around 152,465 deaths are related to CVD. Critical risk factors for CVD, CHD, Stroke, and other heart diseases include detrimental stress, depression, excessive alcohol use, excessive smoking, high blood pressure, diabetes, obesity, and a poor diet that contains cholesterol. As a result, people were encouraged to prioritize preventative healthcare, which implies that people are spending a lot of money on smart wearable healthcare gadgets. This will fuel the expansion of wearable cardiac device industry.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS24744/

Competitive Landscape

The key players in the UK Wearable Cardiac Devices Market are Boston Scientific Corporation, iRhythm Technologies, Inc., Asahi Kasei Corporation (ZOLL Medical Corporation), Qardio, Inc., Otsuka Holdings Co., Ltd. (Proteus Digital Health), CONMED Corporation, Sky Labs, MedtronicSAMSUNG, Baxter (Welch Allyn), Fitbit Inc., Apple Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CardioScan, CardioSTAT (Icentia Inc.), and Koninklijke Philips N.V., among others.

Recent Developments in the UK Wearable Cardiac Devices Market:

• In December 20222, Mindray introduces new wearable patient monitoring system, refining clinicia’s workflow to track patient conditions. “mWearTM” supports comprehensive and precise measurements of patient status, integrating 6 key vital signs powered by Anti-motion Algorithm, specialized health parameters, status indicators and time analysis. mWearTM features two monitoring modes, Wearable Mode and Continuous Mode, for caregivers to get patient status updates accordingly to the customize setting, and intelligently triggers emergencies and alarm escalations to ensure timely response to patient deterioration.
• In September 2022, Apple introduced Apple Watch Series 8 and the new Apple Watch SE, which bring ground breaking technology and performance, and important safety innovations to the two best-selling smartwatches. The new Apple Watch SE delivers the core Apple Watch experience, including Activity tracking, high and low heart rate notifications, and Emergency SOS, as well as the new Crash Detection feature.
• In August 2022, Medtronic plc announced the completion of its acquisition of Affera, Inc. This purchase broadens the company’s cardiac ablation offering by adding its inaugural cardiac mapping and navigation platform, which includes a distinct, fully integrated diagnostic, focused pulsed field, and radiofrequency ablation solution.

UK Wearable Cardiac Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current UK Wearable Cardiac Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of UK Wearable Cardiac Devices Market in terms of revenue ($Million)
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the UK Wearable Cardiac Devices industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the UK Wearable Cardiac Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall UK Wearable Cardiac Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the UK Wearable Cardiac Devices Market are also analyzed.

Global UK Wearable Cardiac Devices Market Segmentation

By Component

• Holter monitors
• Patch
• Defibrillator
• Smart Watches
• Others

By Enterprise Size

• Home Healthcare
• Remote Patient Monitoring
• Sports And Fitness
• Others

By End-user

• Hospitals
• Retail Pharmacies
• Academic Institutes
• Others

By Region

• England
• Wales
• Scotland
• Ireland

Key Players

• iRhythm Technologies Inc
• Welch Allyn (Hillrom Services Inc
• ZOLL Medical Corporation
• Qardio Inc
• Proteus Digital Health
• CONMED Corporation
• NuVasive, Inc.
• Sky Labs
• Medtronic
• Samsung
• Fitbit Inc.
• Apple Inc.

New York, July 2023: According to a new research study by Global Insight Services (GIS), the endoscopy equipment market is expected to grow rapidly over the next 10 years to reach a value of more than USD $56.8 billion by 2032.

One of the most popular medical imaging devices in use today is the endoscope. Endoscopes are introduced by a physician or surgeon right into the organ, in contrast to conventional imaging tools. The endoscope has a camera and light on one end, which the doctor can use to view the visual in real time on a screen. To view detailed images of the intestinal wall and surrounding organs, ultrasound endoscopes use sound waves rather than cameras. These tools are also useful for inserting endoscopic implants in addition to imaging.

Request Sample Pages of this Research Report: 

https://www.globalinsightservices.com/request-sample/GIS10279/

Global Endoscopy Equipment Market: Key Drivers

Endoscopy operations are minimally invasive surgical procedures that involve the use of small tubes, miniature cameras, and surgical tools through one or more small incisions. The main benefits of endoscopic procedures include less pain, a shorter or no hospital stay, or fewer difficulties with pre- and post-surgery treatment. Because of this, these operations are more affordable, more successful, and safer than conventional open surgeries. Additionally, health insurance companies in wealthy nations including the United States, Canada, the United Kingdom, Germany, Australia, and a few Middle Eastern nations like the United Arab Emirates cover these operations. These elements contribute to both patients’ and doctors’ strong preferences for endoscopic operations. In the US, there are roughly 11.0 million colonoscopies conducted annually, 6.1 million upper endoscopies, 313,000 flexible sigmoidoscopies, 178,400 upper endoscopic ultrasonography exams, and 169,500 Endoscope Reprocessing procedures.

Report Findings

https://www.globalinsightservices.com/reports/endoscopy-equipment-market/

The endoscope segment is likely to account for the majority of the market share during the forecast period

The key factors attributing the growth of the market is higher adoption rate of these equipment coupled with rising preference of patients and doctors for minimally invasive procedures, and doctors for minimally invasive procedures, and ongoing advancements in endoscopy technologies.

The gastrointestinal endoscopy segment is likely to dominate the market during the forecast period

The largest share of the segment is attributed to the increasing geriatric population in the US, China, Japan and India and the rising incidence of colorectal cancer in younger adults, which leads to growing awareness of the target population of CRC screening.

The hospital segment is likely to dominate the endoscopy equipment market during the forecast period

The growing adoption of endoscope equipment in hospitals coupled with increasing government and private funding in the healthcare sector, as well as the greater availability of skilled healthcare professionals and technologically advanced facilities are boosting the growth of the market.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10279/

Competitive Landscape

The key players in the market are Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), JOHNSON & JOHNSON (US), Fujifilm Holdings Corporation (Japan), Medtronic Inc. (Ireland), Hoya Corporation (Japan), Nipro Corporation (Japan), Smith & Nephew Plc (UK), Richard Wolf GmbH (Germany), ConMed Corporation (US), Intuitive Surgical, Inc. (US), Cook Medical (US), Ambu A/S (Denmark), CapsoVision, Inc. (US), Fortimedix Surgical B.V. (Netherlands), B. Braun Melsungen AG (Germany), Medi-Globe (Germany), The Cooper Companies, Inc. (US), Dantschke Medizintechnik (Germany), Laborie Medical Technologies Inc. (Canada), Teleflex Incorporated (US), Cantel Medical Corp. (US), Carl Zeiss AG (Germany), and Arthrex, Inc. (US).

Global Endoscopy Equipment Market: Recent Developments

• February 2021, Olympus Corporation launched the SIF-H190 single balloon enteroscopy solution to reach deep into the small intestine.
• June 2021, Johnson & Johnson has launched the ENSEAL X1 curved Jaw Tissue Sealer, an advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissues.
• April 2021, Medtronic Plc, has launched the GI Genius Intelligent endoscopy module in the United States.
• June 2021, Smith & Nephew, has launched the Real Intelligence suite of enabling technology solutions, which includes the next-generation robotics platform and the CORI surgical system, in Australia and New Zealand.

Report Coverage:

•  The report offers a comprehensive quantitative as well as qualitative analysis of the current Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of Market in terms of revenue ($Million).
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the Market along with the current trends and future estimations to depict imminent investment pockets. The overall industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Market are also analyzed

Global Endoscopy Equipment Market Segmentation

By Product

• Endoscope
• Visualization System
• Other Endoscope Equipment
• Accessories

By Application

• Gastrointestinal Endoscopy
• Laparoscopy
• Obstetrics/Gynecology Endoscopy
• Arthroscopy
• Urology Endoscopy
• Bronchoscopy
• ENT Endoscopy
• Mediastinoscopy
• Other

By End User

• Hospitals
• Ambulatory Surgery Centers/Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Gastrointestinal Stent Market to Reach USD 796 Million by 2032, driven by the growth in incidences of gastrointestinal cancers across the globe: Global Insight Services

New York, July 2023: According to a new research study by Global Insight Services (GIS), the global gastrointestinal stent market is expected to grow rapidly over the next 10 years to reach a value of more than USD 796 million by 2032.

Gastrointestinal (GI) stents are made to provide palliative care for a variety of illnesses that clog the GI tract. The recanalization of gastrointestinal (GI) malignancies and postoperative leak sealing are two important functions of GI stents. Drug-eluting devices, tissue modeling for benign disorders, and GI tract drainage/anastomosis are among more possible uses for GI stents. The rise in gastrointestinal malignancies and other digestive illnesses, changing lifestyles, rising healthcare spending on gastrointestinal treatments, and growing desire for less invasive surgery are all factors contributing to the growth of the global market for gastrointestinal stents.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10289/

Gastrointestinal Stent Market: Key Trends and Drivers

The increase in the incidence of gastrointestinal cancers, IBD, and other digestive diseases is propelling the growth of the market. One of the biggest causes of death in the globe is gastrointestinal cancer. Morbidity and mortality from chronic diseases like esophageal cancer, colorectal cancer, and serious gastrointestinal disorders have sharply increased in recent years. According to the International Agency for Research on Cancer (IARC), gastrointestinal malignancies accounted for 35 percent of all cancer-related fatalities and 26 percent of the global burden of cancer incidence in 2018. The WHO estimates that stomach cancer caused 769,000 deaths worldwide in 2020, whereas gastrointestinal malignancies like colorectal cancer cause 935,000 deaths. 1.93 million new instances of colorectal cancer were detected worldwide in 2020, making it the third most frequent cancer overall.

Gastrointestinal Stent Market: Market Restraints and Challenges

The high cost of the procedure and limited reimbursement in developing countries is anticipated to hinder the growth of the market. Globally, the cost of healthcare has dramatically climbed in recent years, as have the costs of medical devices like GI stent. Approximately USD 43,798.06 is the average cost of an endoscopic stenting treatment, according to a study published by PubMed.gov in May 2021. In developing nations like India and Brazil, healthcare providers and payers have limited financial means to spend in such an expensive surgery. One of the main reasons why patients and doctors are reluctant to choose gastrointestinal stents is the fact that endoscopic stenting operations are seldom or never reimbursed by governments in most Asian nations. It is anticipated that the high price and lack of reimbursement in developing nations like India may restrict the use of gastrointestinal stent-related treatments by patients.

Gastrointestinal Stent Market Report Findings

https://www.globalinsightservices.com/reports/gastrointestinal-stent-market/

The biliary stents segment accounted for the largest share in 2022

Based on product, it is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents. The biliary stents segment accounted for the largest share in 2022. The biliary stent segment is anticipated to grow at the highest CAGR during the forecast period. One of the key drivers behind the expansion of the biliary stents market is the rising incidence of bile duct cancer and chronic liver disease. Additional important factors that are anticipated to promote the growth of this market segment during the projected period include the rising incidence of biliary disorders and the rise in the number of surgical procedures for the treatment of biliary diseases.

The self-expanding metal segment is anticipated to dominate the market during the forecast period

Based on material, it is segmented into self-expanding metal stents and plastic stents. The Self-expanding metal stents are further sub-segmented into nitinol, stainless steel, and other metal stents. The self-expanding metal segment is anticipated to dominate the market during the forecast period. Factors like the rising demand for self-expanding metal stents because of its benefits, including ease of insertion, a reduced risk of dislodgment or migration, and extended patency. Stainless steel, nitinol, cobalt-chromium, and platinum-chromium with or without coating are the typical materials used to make metal stents. Benign gastrointestinal leaks and perforations are treated with self-expanding metal stents. These stents serve as a support to maintain the digestive tract open and allow for simple, unhindered outflow of food and liquids.

The biliary diseases segment accounted for the majority of market share during the forecast period

Based on application, it is segmented into biliary diseases, irritable bowel syndrome, and gastrointestinal cancers. The biliary diseases segment accounted for the majority of market share during the forecast period. The gastrointestinal cancers segment is anticipated to have the highest share during the projection period. The rise in prevalence and incidence of gastrointestinal malignancies is thought to be the cause of this market segment’s expansion. For instance, the American Cancer Society’s Colorectal Cancer Facts & Figures 2020-2022 report estimates that in the US in 2020, 43,340 new cases of rectal cancer and 104,610 new instances of colon cancer would be detected.

The hospital end user segment is anticipated to dominate the market during the forecast period

Based on end user, it is segmented into hospitals & clinics, and ambulatory surgical centers. The hospital end user segment is anticipated to dominate the market during the forecast period. Due to the high volume of endoscopic retrograde cholangio-pancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures carried out in hospitals for a variety of disease indications, favorable reimbursement scenarios, and increased government initiatives to provide high-quality treatment for digestive disorders, this segment has a sizable market share.

North America had the biggest market share for gastrointestinal stents, followed by Europe and the Asia-Pacific region

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America had the biggest market share for gastrointestinal stents, followed by Europe and the Asia-Pacific region. The market in the Asia Pacific is anticipated to expand at the greatest CAGR over the forecast period. The APAC region’s market is growing primarily as a result of factors such as an aging population, an increase in gastrointestinal illnesses, a rise in per capita income and life expectancy, as well as increased investments by major market participants in the area.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10289/

Competitive Landscape

The key players studied in the global gastrointestinal stent market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), and Taewoong Medical (South Korea) among others.

Recent Developments in the Gastrointestinal Stent Market:

• November 2020, Boston Scientific Corporation has received 510(k) approval from the U.S. Food and Drug Administration and CE Mark approval to market its Wall Flex fully covered esophageal stent for the treatment of malignant esophageal strictures caused by esophageal cancer.
• October 2020, Olympus Corporation launched Hanaro Stent Espophagus TTS self-expanding metal stents made by MI-Tech and distributed exclusively through Olympus in the US.
• June 2019, Merit Medical System Inc. acquired Brightwater Medical Inc. has received the FDA clearance for the ConvertX biliary stent device.
• June 2018, Cook Medical entered into the US. The new deal comprises the Niti-S Esophageal Stent, the flagship product of Taewoong Medical’s Self-expandable line of metal GI stents.

Gastrointestinal Stent Market Report Coverage:

•  The report offers a comprehensive quantitative as well as qualitative analysis of the current Gastrointestinal Stent Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
•  The report also covers qualitative as well as quantitative analysis of Gastrointestinal Stent Market in terms of revenue ($Million).
•  Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Gastrointestinal Stent industry.
•  A thorough analysis of market trends and restraints is provided.
• By region as well as country market analysis is also presented in this report.
•  Analytical depiction of the Gastrointestinal Stent Market along with the current trends and future estimations to depict imminent investment pockets. The overall Gastrointestinal Stent industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
•  Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Gastrointestinal Stent Market are also analyzed

Global Gastrointestinal Stent Market Segmentation

By Product

• Biliary Stents
• Duodenal Stents
• Colonics Stents
• Pancreatic Stents
• Esophageal Stents

By Material

• Self-expanding Metal Stents
• Plastic Stents

By Application

• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers

By Region:

•  North America
  •  The U.S.
  • Canada
  •  Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  •  Italy
  • Netherlands
  • Sweden
  • Switzerland
  •  Denmark
  • Finland
  •  Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  •  Rest of Asia-Pacific
•  Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Boston Scientific Corporation (US)
• Cook Group (US)
• Medtronic plc. (Ireland)
• ELLA-CS, s.r.o. (Czech Republic)
• Becton, Dickinson and Company (US)
• Merit Medical Systems (US)
• CONMED Corporation (US)
• Cantel Medical (US)
• Olympus Corporation (Japan)
• Taewoong Medical (South Korea)

Global Diabetes Devices Market to Reach US$ 8.0 BN by 2032, driven by growth in medical applications: Global Insight Services

New York, July 2032: According to a new research study by Global Insight Services (GIS), the diabetes devices market is expected to grow rapidly over the next 10 years to reach a value of more than the US $8.0 billion by 2032.

Diabetes is a disorder that occurs when the blood glucose levels rise over normal levels, due to a defect in insulin production that controls glucose levels. Blood glucose acts as the main source of energy and can be obtained from the food we consume. Insulin, the pancreatic hormone maintains blood glucose levels. Defect in the synthesis of insulin in the body cannot regulate the blood glucose level and causes diabetes. The Blood glucose level range in a normal individual is 70 – 100 mg/dL and in a diabetic patient it raises up to 80 – 130 mg/dL. Diabetes care devices are employed to monitor the glucose levels of a diabetic patient. A continuous glucose monitor (CGM) is a medical device that tracks and monitors the blood glucose of a diabetic patient during the day.

Request Sample Pages of this Research Report: 

https://www.globalinsightservices.com/request-sample/GIS10117/

Global Diabetes Devices Market: Key Drivers

The key factors such as an increase in the incidence of diabetes owing to aging, obesity, and unhealthy lifestyle is one of the factors contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to WHO, in 2016, over 1.9 billion adults were overweight, of which, around 650 million people were obese. Risk factors, like obesity and overweight, are leading to a rise in the incidence of diabetes. Owing to that, risk factors like smoking, overweight, obesity, and high cholesterol levels are anticipated to boost the prevalence of diabetes, so fueling the need for diabetes devices.

Market Restraints and Challenges

The major factor hindering the growth of the market is that the blood glucose monitoring devices do not measure the exact level of glucose in the blood but give a range of blood glucose levels. Adding to these, the adverse effects related to some of the diabetes care devices are hindering the growth of the market.

Report Findings

https://www.globalinsightservices.com/reports/diabetes-devices-market/

The blood glucose monitoring systems segment is likely to dominate the market during the forecast period

Based on type, it is segmented into blood glucose monitoring systems. Self-monitoring blood glucose monitoring systems, continuous glucose monitoring systems, test strips/test papers, lancets/lancing devices, insulin delivery devices, insulin pumps, insulin pens, insulin syringes and needles, and diabetes management mobile applications. The blood glucose monitoring systems segment is likely to dominate the market during the forecast period. The key factors such as convenience, simplicity of use coupled with utility in providing real time insights related to diabetic conditions to patients and healthcare professionals for integrated diabetes management are boosting the market growth.

The hospitals & specialty clinics segment is likely to dominate the market during the forecast period

Based on end user, it is segmented into hospitals & specialty clinics, and self & home care. The hospitals & specialty clinics segment is likely to dominate the market during the forecast period. The key factors such as technological innovations coupled with a rising focus to reduce the chances of infections and accidental pricking to increase the growth of the market during the forecast period.

The North America region is likely to dominate the market during the forecast period

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market during the forecast period. High per capita income coupled with increasing healthcare spending are the key factors boosting the growth of the market during the forecast period. The large diabetic population and favorable reimbursement policies are also boosting the growth of the market.

Have a question for our analyst: 

https://www.globalinsightservices.com/inquiry-before-buying/GIS10117/

Competitive Landscape

The key players in the diabetes devices market are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan), among others.

Recent Developments

• February 2020, Abbott received US FDA approval for the use of Free Style Libre 14-day Flash glucose monitoring systems in hospitals.
• February 2020, Insulet signed a commercialization agreement with DexCom Inc., to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.
• April 2020, Ypsomed entered into a partnership with DexCom, Inc. to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.
• January 2020, Life Scan entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sale of Life Scan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.
• December 2019, Eli Lily and Company announced a global commercialization agreement to integrate DexCom, Inc., products into Lilly’s personalized diabetes management system, currently in development, to advance the treatment of diabetes.

Market Segments

By Type

• Blood glucose monitoring systems
• Self-monitoring blood glucose monitoring systems
• Continuous glucose monitoring systems
• Test strips/Test papers
• Lancets/Lancing devices
• Insulin delivery devices
• Insulin pumps
• Insulin pens
• Insulin syringes and needles
• Diabetes management mobile applications

By End User

• Hospitals & Specialty Clinics
• Self & Home Care

By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russia
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • Middle East
  • Africa

Medical Power Supply Market to Reach US$ 2.4 bn by 2032, driven by growing demand for portable and home-based devices: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global medical power supply market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 2.4 billion by 2032.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10327/

Medical Power Supply Market: Key Trends and Drivers

Increasing accessibility by major product manufacturers will `fuel the industry growth. Many market players have begun to offer products on their websites or third parties, thus greatly expanding product accessibility. By increasing visibility and reach, companies can boost revenue significantly. E-commerce websites already have a well-established presence in many countries, and this also helps the company expand reach to regions otherwise not penetrated or accessible.

Medical Power Supply Market: Restraints & Challenges

Technical limitations of power supply may restraint the market growth. Conventional power supply assemblies are associated with several technical limitations: limited power optimization, substantial functional noise, device overheating, and low detection quality of target biomolecules. Therefore, there is a constant customer need for novel power supply assemblies, and a long-term gap between development and commercialization of the same is expected to restrain the growth of the global market. However, this may be mitigated through industry-academia collaborations and industry-customer partnerships to develop novel components as per changing user needs.

Medical Power Supply Market Report Findings

https://www.globalinsightservices.com/reports/medical-power-supply-market-forecast-to-2031-global-insight-services/

The DC to DC power supply segment is likely to hold a dominant medical power supply market share and grow at a substantial CAGR during the forecast period.

Based on technology, it is segmented into AC to DC power supply, and DC to DC power supply. In 2022, DC to DC power supply segment dominated the market and accounted for the largest revenue share. The growth of this segment is anticipated to A DC to DC power supply converts a direct current (DC) input supply to a DC output supply typically at a different voltage level. There are many different types of DC power supply converters available, which are grouped into three categories: linear DC power supplies, switching DC power supplies, and switching flyback. They are increasingly used in portable electronic devices such as cellular phones and laptop computers. DC-DC converters are widely used to efficiently produce a regulated voltage from a source that may or may not be well controlled to a load that may or may not be constant

The open frame power supply segment is anticipated to hold a majority of the medical power supply market size throughout the study period.

Based on type, it is segmented into open frame power supply, enclosed power supply, adapter power supply, and converters. Among them, open frame power supply segment accounted for significant share in 2022. An open frame power supply may consist of a frame without a lid, a simple chassis plate, or even just a separate PCB, depending on the intended application. The power range is very extensive, and the design can also be tailored exclusively to specific markets such as for the medical or industrial sectors.

The diagnostic imaging and monitoring equipment segment is anticipated to hold a majority of the medical power supply market size throughout the study period.

Based application, it is segmented into diagnostic, imaging, and monitoring equipment, surgical equipment, home medical equipment and others. Among them, diagnostic, imaging, and monitoring equipment segment is expected to grow with the highest CAGR during the forecast period. Diagnostic and Monitoring Equipment is Expected to Hold Significant Market Share

Power supply products and technology play a critical role in medical imaging, diagnostics, monitoring equipment, and therapeutic businesses. From generating X-rays to powering detectors, these varied voltage power supply and X-ray generator solutions enable and improve the delivery of medical treatment. The increase in the number of government initiatives for the diagnosis of infectious disease and the rising need for fast detection of diseases are contributing to the growing demand for diagnostic and monitoring equipment across the world. Governments are proactively investing in many research studies, including those for the diagnosis of infectious diseases. Technology holds a central role in expanding the market for diagnostic and monitoring devices. The increase in the aging population and the transformation of acute illnesses, such as heart failure into chronic diseases, indicate that the number of patients is also increasing. All the aforementioned factors are expected to contribute to the huge market share of the segment.

The Asia Pacific region is estimated to exhibit the highest growth rate during the medical power supply market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific accounted for the significant market share and expected to register the fastest CAGR from 2023 to 2032. It is expected to be dominant in the medical power supply devices market in the long run. Over the next five years, the growth of the market in the Asian region is likely to be centered in China, India, Taiwan, South Korea, and Singapore. The growth mentioned above will be driven by the improvement in the standard of living, greater access to medical treatment. Plus, the more prominent supply manufacturers are opening their manufacturing facilities in the Asian subcontinent; especially in China. This is fueling the growth of the medical power supply market in the region.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10327/

Competitive Landscape

The global medical power supply market report includes players such as Advanced Energy Industries (US), Delta Electronics (Taiwan), TDK-Lambda Corporation (Japan), SL Power Electronics (US), XP Power (Singapore), Spellman High Voltage Electronics Corporation (US), COSEL (Japaan), FRIWO Gerätebau (Germany), Bel Fuse (US), and MEAN WELL Enterprises (Taiwan), among others. In addition, major vendors are focused on developing smarter technologies for surface disinfections. For instance, in September 2021, New Yorker Electronics announced its release of the new Polytron Devices PFMUIC700 Series of AC-DC power supplies designed for medical applications. The Polytron PFMUIC700 series features ultra-compact size of 6.7 x 3.66 x 1.61 inch (170.2 x 93.0 x 41.0mm) in a fully enclosed plastic case.

Recent Developments in the Medical Power Supply Market:

• In August 2021 – CUI, a Bel group company, announced the addition of 12 new models to its VMS-C and VMS-C-CNF range of internal medical ac-dc power supplies. These new, higher power models are chassis-mount units, available in open-frame or metal-case variations that are ideal for use in medical and home healthcare applications, such as ultrasound machines and medical beds.
• In June 2021 – Powerbox announced 300% peak power open-frame power supplies for medical and industrial applications. For medical applications, the AEA600F input to output isolation complies with 2MOPP, its input to the ground with 1MOPP, and output to the ground with 1MOPP making the product suitable for the Body Floating (BF) applications. The units are approved under ANSI/AAMI ES60601-1 and EN60601-1 3rd Edition.
• In December 2020 – CUI Inc. announced the addition of two 120-watt ac-dc external power supply series, expanding its existing 60601 certified medical power supply family. The new series footprint is 35% smaller than its non-medical counterpart, providing a lighter and less cumbersome adapter that can power a wide range of medical and dental devices.
• In April 2020 – XP Power released its new UCH600 series of convection cooled, 600W AC-DC power supplies. The ultra-compact power supplies do not require additional cooling and deliver full load power under a wide range of conditions. This series can be used in medical devices, as well as for industrial electronics applications.

Medical Power Supply Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global medical power supply market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future medical power supply market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the medical power supply market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global Medical Power Supply Market Segments

By Technology

• AC to DC Power Supply
• DC to DC Power Supply

By Type

• Open Frame Power Supply
• Enclosed Power Supply
• Adapter Power Supply
• Converters

By Application

• Diagnostic, Imaging, and Monitoring Equipment
• Surgical Equipment
• Home Medical Equipment
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players Profiled in the Report

• Advanced Energy Industries (US)
• Delta Electronics (Taiwan)
• TDK-Lambda Corporation (Japan)
• SL Power Electronics (US)
• XP Power (Singapore)
• Spellman High Voltage Electronics Corporation (US)
• COSEL (Japaan)
• FRIWO Gerätebau (Germany)
• Bel Fuse (US)
• MEAN WELL Enterprises (Taiwan)

Medical Equipment Maintenance Market to Reach USD 121.9 Billion by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global medical equipment maintenance market is expected to grow rapidly over the next 10 years to reach a value of more than USD 121.9 billion by 2032.

To accurately assess patients’ health, medical equipment is used in diagnostic procedures as well as operations and therapies. As a result, maintaining and enhancing the accuracy and precision of medical devices depends greatly on their maintenance. Maintenance of medical equipment makes sure the tools are accurate and error-free. It entails determining the expected lifespan of machinery that ranges from simple devices like sphygmomanometers to complex ones like Magnetic Resonance Imaging (MRI) machines. Additionally, it is involved with frequency-scheduling tasks, fixing broken equipment, optimizing, and deciding on maintenance schedules based on user data. With the rise in demand for refurbished medical equipment and the incidence of life-threatening disorders, there has been a growing necessity for maintaining medical equipment in recent years.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10325/

Medical Equipment Maintenance Market: Key Trends and Drivers

In recent years, as healthcare organizations have worked to improve patient safety and care quality, there has been a greater emphasis on preventive maintenance of medical equipment. This entails a properly planned program where scheduled maintenance chores are carried out to prevent greater and more expensive problems in the future. Additionally, it aids in lowering equipment downtime, improving device reliability and enhancing daily operations.

Preventive maintenance strategies are becoming more popular as planned inspections and maintenance of medical devices help prevent unfavorable incidents and accidents involving medical devices. The safe, effective, and long-lasting use of medical devices is guaranteed by routine maintenance services. In the upcoming years, development possibilities for service providers are anticipated as a result of the increasing emphasis that healthcare organizations are placing on the implementation of preventative maintenance practices.

Medical Equipment Maintenance Market: Restraints and Challenges

Healthcare professionals can track and monitor the state of medical devices through maintenance programmes, ensuring effective use and optimal uptime. Given the present emphasis on preventive maintenance and cost pressures, this is especially crucial in order to control total expenditure in the context of austerity measures. These initiatives involve the use of cutting-edge technology-based asset management solutions. However, the deployment of these solutions comes with high initial installation costs and hefty maintenance costs, whilst the installation of advanced medical equipment comes with a service contract cost that must be paid on a yearly basis (around 12% of the cost of the medical equipment). Consequently, during the equipment’s lifetime, the servicing costs incurred are typically higher than the equipment’s purchase price. End customers are being discouraged from utilising advanced medical technology because of the high expense of installation and upkeep.

Medical Equipment Maintenance Market Report Findings

https://www.globalinsightservices.com/reports/medical-equipment-maintenance-market/

The imaging equipment segment is anticipated to dominate the market during the forecast period

Based on the equipment, it is segmented into imaging equipment, electromedical equipment, endoscopic devices, surgical instruments, and other. The imaging equipment segment is anticipated to dominate the market during the forecast period. This can be ascribed to the emergence of non-invasive and robotic methods enhancing global surgical operations. In the United States, around 1.8 million cosmetic surgery procedures were carried out in 2019, according to the Plastic Surgery Statistics Report.

The corrective maintenance segment is anticipated to dominate the market during the forecast period

Based on the service, it is segmented into preventive maintenance, corrective maintenance and operational maintenance. The corrective maintenance segment is anticipated to dominate the market during the forecast period. Correcting a device breakdown or component failure that has happened or has intermittently happened in the device is an unplanned activity. Following an unanticipated failure, corrective maintenance activities include the replacement or restoration of any systems or components needed to restore the physical integrity, aesthetic appeal, and/or functional capabilities of a medical device.

The North American region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. The strong base of healthcare facilities, particularly hospitals and diagnostic imaging centers, and the expanding installation base for cutting-edge medical technology in healthcare facilities are mostly to blame for the market’s rise. In 2020, the US held the greatest market share. The strong independent service provider base, in-house maintenance, and expanding medical device installation base in healthcare institutions are primarily responsible for the market growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10325/

Competitive Landscape

The key players studied in the report are GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), Canon, Inc. (Toshiba Medical System Corporation, Japan), Agfa-Gevaert Group (Belgium), Carestream Health, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Hitachi Medical Corporation (Japan), Althea Group (Italy), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), KARL STORZ GmbH & Co. KG (Germany), and Aramark Services, Inc. (US) among others.

Recent Developments

• July 2022, B. Braun launched Technical Service Center to provide quality-driven medical equipment repair and maintenance services to support the Thailand public health system.
• May 2022, Medical Manufacturing Technologies, expanded its catheter manufacturing solutions offering with the acquisition of Medical Production Technology Europe (MPT). They provides equipment and process development services centered on balloon forming, folding and pleating, thermal bonding, and stent crimping solutions.
• March 2021, FUJIFILM Corporation acquired the Diagnostic Imaging-related Business of Hitachi, Ltd. To support R&D, manufacturing, marketing and maintenance services for diagnostic imaging systems, electronic medical records, and other medical related products & services.
• February 2021, Siemens Healthineers entered into an eight-year technological partnership with Kantonsspital Baden for procurement & maintenance of medical imaging systems, technology management, and the expansion of telemedicine solutions.
• December 2019, GE Healthcare signed a six-year service contract for imaging technologies across Affidea’s network in the Netherlands.

Medical Equipment Maintenance Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Medical Equipment Maintenance market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Medical Equipment Maintenance market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Medical Equipment Maintenance market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Medical Equipment Maintenance industry.

Global Medical Equipment Maintenance Market Segmentation

By Equipment

• Imaging Equipment
• Electromedical Equipment
• Endoscopic Devices
• Surgical Instruments
• Other

By Service

• Preventive Maintenance
• Corrective Maintenance
• Operational Maintenance

By Region

• North America  

• • The U.S. 
  • Canada 
  • Mexico 

• Europe 

• • The U.K. 
  • Germany 
  • France 
  • Spain 
  • Italy 
  • Netherlands 
  • Sweden 
  • Switzerland 
  • Denmark 
  • Finland 
  • Russia 
  • Rest of Europe 

• The Asia-Pacific 

• • China 
  • India 
  • Japan 
  • South Korea 
  • Australia 
  • Singapore 
  • Indonesia 
  • Taiwan 
  • Malaysia 
  • Rest of Asia-Pacific 

• Rest of the World 

• • Latin America 
  • The Middle East 
  • Africa

Key Players

• GE Healthcare (US)
• Siemens Healthineers (Germany)
• Koninklijke Philips N.V. (Netherlands)
• Medtronic plc (Ireland)
• FUJIFILM Holdings Corporation (Japan)
• Canon, Inc. (Toshiba Medical System Corporation, Japan)
• Agfa-Gevaert Group (Belgium)
• Carestream Health, Inc. (US)
• Drägerwerk AG & Co. KGaA (Germany)
• Hitachi Medical Corporation (Japan)
• Althea Group (Italy)
• Olympus Corporation (Japan)
• B. Braun Melsungen AG (Germany)
• KARL STORZ GmbH & Co. KG (Germany)
• Aramark Services, Inc. (US)

Demineralized Bone Matrix (DBM) Market to Reach US$ 620.2 Bn by 2032, driven by growing awareness about the importance of data security: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global Demineralized Bone Matrix (DBM) Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 620.2 Billion by 2032.

DBM is a bone graft substitute that is composed of demineralized bone matrix. This matrix is derived from donor bone that has been subjected to a process called demineralization. This process removes the inorganic bone minerals, leaving a scaffold of collagen and other proteins that can support new bone growth. DBM has been shown to be an effective way to promote new bone growth and has been used in a variety of orthopedic applications.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS21712/

Demineralized Bone Matrix (DBM) Market: Key Trends and Drivers

The growing prevalence of orthopedic disorders, including musculoskeletal conditions and osteoarthritis, is expected to drive the demand for demineralized bone matrix (DBM). Factors such as an increasing number of spinal fusion and dental surgeries, coupled with a growing patient population worldwide, contribute to this market growth. The World Health Organization reported that approximately 1.71 billion people globally had musculoskeletal conditions in July 2022. In Europe, the International Osteoporosis Foundation plays a vital role in raising awareness of osteoporosis care. According to a National Institute of Health article, the incidence of osteoarthritis in the United Kingdom was 6.8 per 1,000 people in 2021, with a prevalence of around 10.7%. Given the high prevalence of orthopedic disorders, DBM is expected to be in high demand as an important therapeutic option for these conditions.

Demineralized Bone Matrix (DBM) Market: Restraints & Challenges

One of the key restraints in the Demineralized Bone Matrix (DBM) market is the high cost associated with its production and processing. DBM is derived from donated human bone or animal sources, which involves extensive processing, sterilization, and quality control measures to ensure safety and efficacy. These processes incur significant costs, making DBM products relatively expensive compared to alternative bone grafting materials. As a result, the high cost can limit the adoption of DBM, particularly in regions with limited healthcare budgets or in cases where cost-effectiveness is a crucial factor. Furthermore, the pricing barrier can restrict access to DBM for patients without adequate insurance coverage or in healthcare systems with stringent reimbursement policies. Overcoming the cost restraint and making DBM more affordable would be beneficial in expanding its utilization and improving patient outcomes.

Demineralized Bone Matrix (DBM) Market Report Findings

https://www.globalinsightservices.com/reports/demineralized-bone-matrix-dbm-market/

The gel segment is likely to hold a dominant Demineralized Bone Matrix (DBM) Market share and grow at a substantial CAGR during the forecast period.

By type, the market is segmented into Gel, Putty, and Others. The gel segment held the largest revenue share of more than xx% in 2022. Gel segment plays a significant role in propelling the growth of the Demineralized Bone Matrix (DBM) market. DBM is a biologic material derived from allograft bone that is processed to remove minerals while preserving the natural collagen matrix and growth factors. The gel form of DBM offers several advantages, including ease of handling and application during surgical procedures. The gel matrix provides a scaffold for cell attachment and proliferation, allowing for improved bone regeneration and healing. Furthermore, the gel form enables better integration with the surrounding tissues, enhancing the overall effectiveness of DBM as a bone graft substitute. As a result, the demand for DBM gel is increasing, driving the growth of the DBM market.

The hospital segment is anticipated to hold a majority of the Demineralized Bone Matrix (DBM) Market size throughout the study period.

Based on end-user. The market is categorized into Hospitals, Specialty Clinics, and Others. The hospital segment dominated with a revenue share of over xx% in 2022. The healthcare industry is witnessing a significant surge in the demand for demineralized bone matrix (DBM) within hospitals. DBM, derived from allograft bone, has gained immense popularity due to its exceptional regenerative properties and its ability to promote bone healing and fusion. With an aging population and an increase in musculoskeletal disorders and complex fractures, the need for effective bone graft substitutes has become paramount. DBM offers numerous advantages, including its osteoinductive and osteoconductive properties, biocompatibility, and easy handling. Its versatile nature allows it to be used in a wide range of orthopedic and spinal surgeries, such as spinal fusion, fracture repair, and bone defect reconstruction. As hospitals strive to enhance patient outcomes, DBM has emerged as a crucial tool in the armamentarium of orthopedic surgeons, driving the rising demand for this advanced biomaterial in the hospital setting.

The spinal fusion segment is anticipated to hold a majority of the Demineralized Bone Matrix (DBM) Market size throughout the study period.

By application, the Demineralized Bone Matrix (DBM) Market is classified into Joint, Dental, Spinal Fusion, Craniomaxillofacial, and Others. The Spinal Fusion segment held the largest revenue share of more than xx% in 2022. Spinal fusion is a surgical procedure used to correct issues with the small bones in the spine. By fusing two or more vertebrae together, it creates a solid bone, eliminating painful motion and restoring stability. This procedure is often chosen when movement is the source of pain, caused by conditions like arthritis, injuries, or aging. With a growing number of elderly individuals experiencing spinal disorders, and the increasing use of demineralized bone matrix treatments, this segment is expected to witness significant growth. The United Nations predicts a doubling of the global population aged 65 or above by 2050, reaching 1.5 billion, while the United States has over 55 million individuals in this age group, with California, Florida, and Texas having a significant concentration of senior citizens. Hence aforementioned factors fuels the industry growth.

Moreover, the spine fusion surgery segment is expected to experience substantial growth due to the increasing funding being allocated for the development of products in this field. For instance, Intelligent Implants, which secured EUR 7.5 million (USD 8.7 million) in October 2021 to enhance the comfort of spinal surgeries. Intelligent Implants’ innovative smart implants utilize wireless implantable electronics to stimulate, monitor, and guide bone growth, primarily in spinal fusion procedures that aim to improve stability, address deformities, or alleviate pain by permanently connecting two or more vertebrae. With supportive initiatives and a growing elderly population, this segment is poised for significant expansion in the coming years.

The North America region is estimated to exhibit the highest growth rate during the Demineralized Bone Matrix (DBM) Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest revenue share of over 28.0% in 2021. The dominance is attributable to the improved regulatory norms in countries such as Canada and the U.S. that requires banks to improve data privacy. Public and private banks have also expanded their demand for cryptographic software to safeguard privacy. Additionally, the rise in cyberattacks & the threat to the information that affects business is expected to drive the regional market growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS21712/

Competitive Landscape

The key players in the Demineralized Bone Matrix (DBM) Market Broadcom, ESET North America, IBM Corporation, Intel Corporation, McAfee, LLC, Microsoft, Sophos Ltd., Thales Group, Trend Micro Incorporated and WinMagic, among others..

Recent Developments in the Demineralized Bone Matrix (DBM) Market:

• In October 2022, Paragon 28 Inc. launched its V92-FC+ Cellular Bone Matrix, which is a moldable allograft matrix containing primitive cells designed for use in bone defects and remodeling in the foot and ankle.
• In July 2022, Ossifix Orthopedics launched its demineralized bone matrix, made from 100% human bone tissue.

Demineralized Bone Matrix (DBM) Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Demineralized Bone Matrix (DBM) Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Demineralized Bone Matrix (DBM) Market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Demineralized Bone Matrix (DBM) Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global kidney stones management market.

Global Demineralized Bone Matrix (DBM) Market Segmentation

By Type

• Gel
• Putty
• Others

By Application

• Joint
• Dental
• Spinal Fusion
• Craniomaxillofacial
• Others

By End-user

• Hospitals
• Specialty Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Sweden
  • Switzerland
  • Denmark
  • Finland
  • Russia
  • Rest of Europe
• The Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Taiwan
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• NovaBone Products
• Zimmer Biomet
• Exactech Inc
• AlloSource
• LifeNet Health Inc
• Smith & Nephew
• DePuy Synthes Companies
• Medtronic plc
• Wright Medical Group
• Baxter International

Telehealth & Telemedicine Market to Reach US$ 184.6 bn by 2032, driven by there is an increasing trend towards the use of telehealth and telemedicine services: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global Telehealth & Telemedicine Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 184.6 bn by 2032.

Telehealth is the use of electronic information and telecommunications technologies to support and promote long-distance clinical health care, patient and professional health-related education, public health and health administration. Telemedicine refers to the remote diagnosis and treatment of patients by means of telecommunications technology.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS20052/

Telehealth & Telemedicine Market: Key Trends and Drivers

With the increasing adoption of smartphones and easy availability of technologically advanced devices, innovators have started investing to make the most of the current situation of the industry, by focusing on delivering quality healthcare & comfort through various mobile platforms, which would help patients track their fitness regimes and obtain answers to medical inquiries over the phone, WhatsApp, or through several mobile applications. For instance, several apps, such as Teladoc Health, Doctor Anywhere, Doctor On Call, and ClicknCare, have been introduced to help patients book appointments, track their consultations & medical prescriptions, and store their healthcare information over course of the treatment. Such instances are further boosting the market growth.

Telehealth & Telemedicine Market: Restraints & Challenges

Some of the key restraints and challenges in the Telehealth & Telemedicine Market are:

• There is the issue of reimbursement. Many insurance companies do not yet reimburse for telehealth services, which can be a barrier to adoption.
• There is the question of regulation. There are currently no federal regulations specifically for telehealth, which can create a patchwork of state regulations that can be difficult to navigate.
• There is the challenge of implementation. Telehealth requires both technology and process changes, and can be disruptive to traditional care delivery models.
• Telehealth requires active participation from patients, who may not be used to or comfortable with using technology for their health care.

Telehealth & Telemedicine Market Report Findings

https://www.globalinsightservices.com/reports/telehealth-telemedicine-market/

The software & services segment is anticipated to hold a majority of the Telehealth & Telemedicine Market size throughout the study period.

Based on the deployment, the Telehealth & Telemedicine Market is divided into software and services, and hardware. The services segment held the largest share of xx% in 2022. The need for telehealth applications in real-time monitoring and chronic disease management contributed to the growth of the segment. Moreover, rapid advancements in digital infrastructure, hardware and software components, and increasing penetration of smartphones, and the internet globally further contributed to the segment growth. Moreover, the development of a range of platforms & applications to diagnose, monitor, track fitness & wellness, and prevent disease is boosting the segment growth. The continuously evolving digital space is also expected to positively support the growth of these services.

The software segment is anticipated to witness a lucrative CAGR during the forecast period due to the rising demand for affordable and accessible healthcare services, efficient workflow management, and improved quality care. Rising healthcare costs combined with the growing need to monitor population health accurately and in real-time is increasing the adoption of the software. Moreover, several healthcare institutions in developed nations have shifted to value-based care models to improve patient outcomes. Furthermore, several initiatives have been undertaken by the key players globally, which is driving the segment growth.

The cloud-based segment is anticipated to hold a majority of the Telehealth & Telemedicine Market size throughout the study period.

By component, the industry is bifurcated into Cloud-based, and On-Premise. The cloud-based delivery segment is anticipated to witness the fastest growth rate during the forecast period owing to the increasing adoption of cloud-based applications by healthcare providers and patients and the introduction of technologically advanced solutions. Moreover, seamless data storage and recovery, easy accessibility, high bandwidth, and enhanced security provided by cloud-based applications are contributing to the growth of the segment. Increasing instances of data breaches on the web-based and on-premise telehealth platforms have augmented the demand for the cloud-based delivery segment. Cloud-based solutions enable patient monitoring and teleconsultation for individuals, which require immediate medical assistance in rural and remote locations.

The teleradiology segment is likely to hold a dominant Telehealth & Telemedicine Market share and grow at a substantial CAGR during the forecast period.

Based on application, the industry is categorized into teleradiology, telepsychiatry, telepathology, teledermatology, telecardiology and others the teleradiology segment dominated the market and accounted for the largest revenue share of more than xx% in 2022. This is because of factors, such as an increase in imaging practices, teleradiology workflow adoption by healthcare providers, expansion of service offerings within radiology sub-segments, and the streamlining & regulation of teleradiology practices. The integration of Artificial Intelligence (AI) into teleradiology, implementation of Picture Archiving and Communication System (PACS), and growing R&D activities pertaining to eHealth are key growth propellers over the forecast period.

Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd., for instance, is a telemedicine service provider specializing in customized, high-quality, and affordable radiology reporting solutions for dental specialists and practices. Telepsychiatry, on the other hand, is projected to grow at the fastest CAGR from 2022 to 2032. This is owing to the growing prevalence of mental health disorders, behavioral disorders, rising awareness, and adoption of telepsychiatry services. MD Live, for instance, offers sessions with counselors and psychiatrists for a range of conditions including anxiety, depression, trauma & PTSD, panic disorders, and more.

The providers segment is anticipated to hold a majority of the Telehealth & Telemedicine Market size throughout the study period.

Based on end-user, the Telehealth & Telemedicine Market is divided into providers, payers, and consumers. The provider segment accounted for the largest revenue share of 53.0% in 2022 due to the increasing adoption of telehealth, teleconsultation, and telemedicine among healthcare professionals to reduce the burden on healthcare facilities. Moreover, the increased convenience offered by these solutions to the healthcare providers to have quick and seamless access to patient health records, real-time quality reporting, improved data management, improved decision-making, and eHealth solutions is expected to further increase the adoption of these services among the providers.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the Telehealth & Telemedicine Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific, on the other hand, is anticipated to be the fastest-growing regional market during the forecast period. This rapid growth can be attributed to the presence of a large patient population pool, increasing internet usage, and rapid demand for healthcare assistance, especially in the rural areas. Emerging economies including India and China are estimated to lead the regional market in the years to come. In March 2021, India Brand Equity Foundation (IBEF) reported that the Indian government launched a telemedicine service-eSanjeevani and completed around 3 million consultations across the nation.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS20052/

Competitive Landscape

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Telehealth & Telemedicine Market include AMC Health, American Well Corporation, Cerner Corporation, CISCO System Inc., General Electric Company, Koninklijke Philips N.V., Cigna Corporation, Medtronic Plc., Siemens AG, Teladoc Health Inc. among others.

Recent Developments in the Telehealth & Telemedicine Market:

• In July 2021, Estshara, a Cairo-based company providing an online platform for health consultations and tele pharmacy services, secured USD 500,000 from Egypt Venture in a seed funding round. The company has more than 2 million users currently with a track record of over 200,000 consultations.
• In May 2021, MediTelecare introduced “MediTely” in the market. It is a direct-to-consumer mobile health technology that focuses on the elderly population living outside long-term care facilities.
• In May 2021, Teladoc Health partnered with Vivo to improve access to quality healthcare in Brazil, specifically through the use of telemedicine.
• In April 2021, Swedish digital health start-up Kry, which offers telehealth service and software tools to connect clinicians with patients for remote consultations, raised EUR 312 million. Nearly 6,000 clinicians are using its telehealth platform and software tools.
• In March 2021, AMD Global announced its integration with PointClickCare Technologies, the leader in cloud-based software technology for the long-term and post-acute care (LTPAC) market.

Telehealth & Telemedicine Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Telehealth & Telemedicine Market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Telehealth & Telemedicine Market potential from 2021 to 2031 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Telehealth & Telemedicine Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global Telehealth & Telemedicine Market Segmentation

By Component

• Software & Services
• Hardware

By Delivery Mode

• Cloud-based
• On-Premise

By Application

• Teleradiology
• Telepsychiatry
• Telepathology
• Teledermatology
• Telecardiology
• Others

By End-user

• Providers
• Payers
• Consumers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• AMC Health
• American Well Corporation
• Cerner Corporation
• CISCO System Inc
• General Electric Company
• Koninklijke Philips N.V.
• Cigna Corporation
• Medtronic Plc.
• Siemens AG
• Teladoc Health Inc.

Digital Pathology Market to Reach US$ 2.4 Bn by 2032, driven by rising prevalence of cancer coupled with increasing focus on improving the efficiency of workflow: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global Digital Pathology Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 2.4 Billion by 2032.

Digital pathology is the practice of storing, viewing and analyzing digital images of tissue samples. These images can be stored on a computer or in a cloud-based system, and can be viewed and analyzed using specialized software. Digital pathology can be used for a variety of purposes, including diagnosing disease, studying the effects of treatments and identifying changes in tissue over time.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS20318/

Digital Pathology Market: Key Trends and Drivers

The digital pathology market is being driven by several factors that are shaping the landscape of healthcare and diagnostics. One of the primary market drivers is the increasing demand for accurate and efficient diagnostic solutions. Digital pathology offers significant advantages over traditional microscopy techniques by enabling the digitization of glass slides, allowing pathologists to access and analyze high-resolution digital images remotely. This enhances collaboration among healthcare professionals, facilitates second opinions, and enables the integration of advanced computational tools for image analysis and machine learning algorithms. Additionally, the growing prevalence of chronic diseases, such as cancer, necessitates improved diagnostic capabilities, and digital pathology provides a platform for enhanced accuracy, faster turnaround times, and improved patient outcomes.

Furthermore, the adoption of telemedicine and remote healthcare services is gaining momentum, especially in remote or underserved areas, and digital pathology plays a crucial role in enabling remote pathology consultations and telepathology services. The ability to transmit digital slides for expert opinions and consultations enhances the efficiency of healthcare delivery and reduces the need for physical sample transportation. With these advantages, the digital pathology market is poised for significant growth as healthcare providers seek innovative solutions to improve diagnostic accuracy, efficiency, and accessibility in the field of pathology.

Digital Pathology Market: Restraints & Challenges

The key restraints and challenges in the digital pathology market are the high initial cost associated with implementing digital pathology systems. These systems require substantial investments in infrastructure, including scanners, image storage, and software platforms. The cost of these technologies can be prohibitive for smaller healthcare institutions and pathology labs, limiting their ability to adopt digital pathology solutions. Additionally, complex regulatory landscape surrounding digital pathology. Different countries have varying regulations and standards for digital pathology, which can create barriers to market entry for companies operating in multiple regions. Compliance with these regulations requires substantial time and resources, further hindering market growth.

Furthermore, the integration of digital pathology systems with existing laboratory workflows and information technology infrastructure can be challenging. Pathology labs often have established processes and systems in place, and incorporating digital pathology technology requires significant changes in workflows and staff training. This transition period can be disruptive and may lead to temporary decreases in efficiency and productivity. Similalrly, data security and privacy concerns also pose restraints to the digital pathology market. Pathology images and patient data are sensitive and confidential, and their storage and transmission must comply with stringent security standards. Ensuring data integrity, protection against unauthorized access, and compliance with privacy regulations can be demanding, especially considering the large volumes of data generated by digital pathology systems.

Digital Pathology Market Report Findings

https://www.globalinsightservices.com/reports/digital-pathology-market/

The software segment is likely to hold a dominant Digital Pathology Market share and grow at a substantial CAGR during the forecast period.

By product, the market is segmented into software, scanner, and storage system. The digital pathology market is experiencing significant growth in the software segment. The demand for advanced software solutions, such as image analysis, telepathology, and laboratory information management systems, is increasing as healthcare providers and researchers embrace digitalization for efficient and accurate diagnosis. The software segment is expected to witness robust growth, driven by technological advancements and the need for streamlined workflows, data management, and collaboration among pathologists and clinicians.

This expansion can also be attributed to the increasing number of cancer cases and the concerted efforts of key industry players to develop cutting-edge digital pathology systems. An example of this is Xybion Corp.’s launch of Pristima XD Digital Pathology in August 2021, which enhances laboratory efficiency by streamlining workflows. Likewise, F. Hoffmann-La Roche Ltd. introduced uPath enterprise software in January 2019, aiming to enhance performance, speed, and usability in the field of digital pathology. The integration of such innovative software solutions significantly contributes to workflow improvements.

The disease diagnosis segment is anticipated to hold a majority of the Digital Pathology Market size throughout the study period.

By application, the Digital Pathology Market is classified into Drug Discovery & Development, Education and Training, and Disease Diagnosis. Out of these, disease diagnosis is expected to experience rapid growth in the coming years due to the rising prevalence of chronic illnesses coupled with the higher adoption of advanced imaging technologies and the increasing demand for accurate and efficient diagnostic solutions. Digital pathology enables remote access to high-resolution digital images of tissue samples, allowing pathologists to collaborate and make faster and more precise diagnoses. This technology offers benefits such as improved workflow efficiency, reduced turnaround time, and enhanced patient care, driving the growth of the disease diagnosis segment in the digital pathology market.

Moreover, key players are increasingly focusing on developing advanced and quick diagnostic techniques to facilitate the seamless exchange of information within and between departments. The integration of digital technologies plays a vital role in improving the efficiency of disease diagnosis, thereby enhancing treatment options. An example of this is the collaboration between PreciseDx and The Michael J. Fox Foundation, which aims to introduce AI-enabled digital pathology technology for the early detection of Parkinson’s disease, even before severe symptoms manifest in patients.

The hsopital and referance laborateries segment is anticipated to hold a majority of the Digital Pathology Market size throughout the study period.

Based on end-user. The market is classified into Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, Hospital and Reference Laboratories, and Others. In 2022, the hospital and reference laboratories sector emerged as the dominant force in the market, capturing a substantial share of xx%. This can be attributed to the increasing demand for accurate and efficient diagnostic solutions, improved patient care outcomes, and the need for streamlined workflows in these healthcare settings. The adoption of digital pathology systems allows hospitals and reference laboratories to enhance collaboration, enable remote consultations, optimize storage and retrieval of digital slides, and leverage artificial intelligence-based image analysis tools, ultimately leading to enhanced efficiency and productivity in pathology practices.

Hospitals continue to be the preferred healthcare facilities for disease diagnosis and treatment, and their significance cannot be overstated. To meet the ever-changing needs of patients, hospitals are focusing on enhancing their laboratory capabilities, with an increasing number of institutions striving to offer a comprehensive range of services within their premises. In line with this trend, many hospitals are adopting digital scanning techniques to enhance patient compliance and expedite the diagnostic process. A noteworthy example of this is Ibex Medical Analytics, which secured a PathLAKE contract in March 2023. Through this partnership, Ibex will leverage AI-powered solutions to support cancer diagnosis across 25 National Health Service (NHS) sites.

The North America region is estimated to exhibit the highest growth rate during the Digital Pathology Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America held the largest market share in the global market. This was primarily attributed to several factors, including government initiatives aimed at advancing pathologies, ongoing investments in research and development, a growing adoption of digital imaging, and the presence of major market players in the region who are focused on delivering improved solutions to the population. For example, PathAI introduced AISight, a digital pathology platform, in March 2023. This platform was made available to 13 prominent health systems, reference laboratories, medical centers, and independent pathology organizations in the United States as part of an Early Access Program. Additionally, the increasing utilization of digital pathology in academic research and disease diagnosis has further contributed to the growth of the regional market.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS20318/

Competitive Landscape

The key players in the Digital Pathology Market Leica Biosystems (Danaher), Hamamatsu Photonics, Inc., Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., Mikroscan Technologies, Inspirata, Inc., 3DHISTECH Ltd., Visiopharm A/S, Huron Technologies International, Inc. among others.

Recent Developments in the Digital Pathology Market:

• In April 2021, the first cloud platform designed specifically for financial services was unveiled by IBM as IBM Cloud for Financial Services. With built-in standards that are followed by the entire ecosystem, this platform is also designed to help financial institutions, their partners, and FinTechs reduce risk while innovating rapidly.
• In March 2023, PathAI launched AISight, a digital pathology platform across the U.S. in 13 leading health systems, reference laboratories, medical centers, and independent pathology organizations to participate in Early Access Program.
• In March 2023, Qritive entered into collaboration with Corista for the integration of AI using the company DP3, a DICOM-compliant pathology software in digital pathology. Such initiatives help in providing better patient care, with novel treatment options, and subsequently reducing laboratory cost expenses.
• In September 2022, Paige entered into collaboration with OptraSCAN for streamlining the adoption of digital pathology technology in the European Union, U.S., and UK. The aim of this partnership is to enhance workflows of oncology and pathology by reducing the barriers to digitizing glass pathology slides.
• In January 2022, Inform Diagnostics launched FullFocus, a digital pathology viewer developed by Paige in its laboratory to use the AI tools that would help in streamlining logistics and allow to achieve faster results.

Digital Pathology Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Digital Pathology Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Digital Pathology Market potential from 2022 to 2022 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Digital Pathology Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global kidney stones management market.

Global Digital Pathology Market Segmentation

By Product

• Software
• Scanner
• Storage System

By Application

• Drug Discovery & Development
• Education and Training
• Disease Diagnosis

By End-user

• Pharmaceutical and Biotechnology Companies
• Academic & Research Institutes
• Hospital and Reference Laboratories
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• Leica Biosystems (Danaher)
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• F. Hoffmann-La Roche Ltd.
• Mikroscan Technologies
• Inspirata, Inc.
• 3DHISTECH Ltd.

Transplantation Market to Reach US$ 28.6 Bn by 2032, driven by Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure: Global Insight Services

New York, June 2023: According to a new research study by Global Insight Services (GIS), the global Transplantation Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 28.6 Billion by 2032.

Transplantation is a medical procedure where an organ or tissue is replaced or transferred from a donor to a recipient who needs it to survive. It can involve vital organs like heart, kidney, or liver or non-vital tissues like corneas, skin, or bone. The aim is to restore function and improve quality of life but it requires compatibility and careful surgical precision Offering hope, longevity, and a chance at renewed existence.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS22270

Transplantation Market: Key Trends and Drivers

The transplantation market is experiencing significant growth, driven by various factors. One of the primary drivers is the increasing prevalence of chronic diseases. Conditions such as end-stage renal disease, liver cirrhosis, heart failure, and lung diseases are becoming more common, resulting in a higher demand for organ transplantation. Transplantation offers a life-saving treatment option for patients with organ failure, which fuels the growth of the market. Advancements in surgical techniques and immunosuppressive drugs are also playing a crucial role in driving the transplantation market. Technological innovations, including minimally invasive procedures and robotic-assisted surgeries, have improved the success rates and outcomes of transplantation procedures. Similarly, the development of more effective immunosuppressive drugs has significantly reduced the risk of organ rejection and improved the long-term survival of transplant recipients..

Transplantation Market: Restraints & Challenges

The transplantation market faces a significant restraint in the form of organ shortage. Despite advancements in medical technology and increased awareness about organ donation, the demand for organs continues to surpass the available supply. This scarcity creates a critical challenge in the field of transplantation, as patients on waiting lists often face prolonged periods of uncertainty and deteriorating health. The shortage of organs can be attributed to various factors, including limited public awareness and education about organ donation, cultural and religious beliefs, and inadequate infrastructure for organ procurement and allocation. Efforts are being made globally to address this issue through initiatives such as public awareness campaigns, improving deceased donor identification and procurement, and exploring alternative sources such as living and xenotransplantation.

Transplantation Market Report Findings

https://www.globalinsightservices.com/reports/transplantation-market/

The tissue product segment is likely to hold a dominant Transplantation Market share and grow at a substantial CAGR during the forecast period.

By product, the market is segmented into tissue products, immunosuppressive drugs, and preservation solution. The tissue product segment held the largest revenue share of more than 62.0% in 2022. The growth of this segment can be attributed to the increasing number of transplantation procedures involving cochlear implants, heart valves, bone marrow, and orthopedic soft tissues. Furthermore, market expansion is being driven by new product developments in this area. To strengthen their market position, manufacturers are actively focusing on new product development, mergers and acquisitions, and collaborations. These strategies enable them to expand their existing product portfolios and enhance their presence in the industry. For example, in September 2016, Stryker Corporation announced the acquisition of Instratek, a prominent manufacturer of minimally invasive soft tissue recession instruments used in procedures involving the ankle, foot, and upper extremities.

The organ transplantation segment is anticipated to hold a majority of the Transplantation Market size throughout the study period.

By application, the Transplantation Market is classified into Organ Transplantation, and Tissue Transplantation. The organ transplantation segment held the largest revenue share of more than xx% in 2022. This is owing to the increasing global number of organ transplantations, which creates a demand for immunosuppressant drugs that need to be regularly purchased by patients. For instance, in 2017, approximately 90,306 kidney transplant procedures were performed worldwide. The continuous advancement in transplantation technology and the introduction of new products by manufacturers are also expected to contribute to the growth of transplant procedures. This includes various types of transplants such as kidney, liver, heart, lungs, and tissues. An example of such advancements is the launch of the generic immunosuppressant drug Tacrolimus by Lupin in November 2020, targeting the prophylaxis of organ rejection in allogeneic liver, kidney, and heart transplants in the U.S. market. Moreover, the presence of well-developed healthcare infrastructure, availability of skilled surgeons, and access to advanced transplantation products are among the key factors driving market growth in these regions.

The hospital segment is anticipated to hold a majority of the Transplantation Market size throughout the study period.

Based on End-user, the market is segmented into hospitals, transplant centers, and others. The hospital segment dominated with a revenue share of over xx% in 2022. This can be attributed to the fact that hospitals serve as primary treatment centers where many organ and tissue transplant procedures are performed. Moreover, the presence of well-established infrastructure in hospitals has contributed to market growth. These hospitals often have access to comprehensive databases that facilitate the quick identification of organ availability, enabling prompt medical intervention.

During the forecast period, the number of transplant centers is expected to experience substantial growth. The increasing demand for transplantation procedures has created a need for a greater number of healthcare centers to meet the unmet needs of patients. Furthermore, government initiatives aimed at promoting organ donation are anticipated to drive market expansion. As an example, the Health Resources and Services Administration’s Division of Transplantation has sponsored four grant programs that specifically focus on increasing the number of organ donors and transplant procedures.

The North America region is estimated to exhibit the highest growth rate during the Transplantation Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America held the largest revenue share of over xx% in 2022. The transplantation market in North America is driven by several factors, including advancements in surgical techniques, increasing prevalence of organ failure diseases, and improved post-transplantation care. The demand for organ transplantation is high due to a growing number of patients with end-stage organ failure and the limited availability of organs for transplantation. Key players in the North America transplantation market include healthcare providers, pharmaceutical companies, medical device manufacturers, and research institutions. These entities are involved in organ procurement, transplantation surgeries, immunosuppressive therapies, tissue typing, and post-transplantation care.

In recent years, there have been significant developments in the field of transplantation in North America. These include innovations in organ preservation techniques, advancements in organ matching and compatibility testing, and the use of immunosuppressive drugs to prevent organ rejection. Additionally, there has been a focus on expanding the pool of available organs through initiatives such as living donor transplantation and deceased organ donation programs. For instance, in 2020, the Human Resource & Services Administration launched the Hospital Organ Donor Campaign in April 2020. This led to an increase in the number of organ donations from the previous year.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS22270

Competitive Landscape

The key players in the Transplantation Market Abbvie, Inc, Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Strykers, 21^st Century Medicine, BiolifeSolutions, Inc, Teva Pharmaceuticals and Veloxis Pharmaceutical, among others..

Recent Developments in the Transplantation Market:

• In April 2023, a team of surgeons in Spain performed world’s first robotic lung transplant, a novel lung transplant method that uses robot labelled as Da Vinci.
• In November 2020, Lupin announced the launch of the generic immunosuppressant drug Tacrolimus in the U.S. market indicated for prophylaxis of organ rejection in the allogeneic liver, kidney, and heart transplant.
• In September 2020 Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant.

Transplantation Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current Transplantation Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• The report also covers qualitative as well as quantitative analysis of the Transplantation Market in terms of value (USD Million) and volume (kilotons).
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Industry.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• Analytical depiction of the Transplantation Market along with the current trends and future estimations to depict imminent investment pockets. The overall industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, Case Studies, and PESTLE analysis of the Transplantation Market are also analyzed.

Global Transplantation Market Segmentation

By Product

• Tissue Products
• Immunosuppressive Drugs
• Preservation Solution

By Application

• Organ Transplantation
• Tissue Transplantation

By End-use

• Hospitals
• Transplant Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• Abbvie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic
• Novartis AG
• Strykers
• 21^st Century Medicine
• BiolifeSolutions, Inc.
• Teva Pharmaceuticals
• Veloxis Pharmaceutical

Artificial Intelligence in Healthcare Market to Reach US$ 45.6 Bn by 2032, driven by the growing demand for functional food and beverages owing to increasing consciousness among people about maintaining a balanced diet with a proper content of essential nutrients: Global Insight Services

New York, May 2023: According to a new research study by Global Insight Services (GIS), the global Artificial Intelligence in Healthcare Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 45.6 Billion by 2032.

Artificial intelligence (AI) in healthcare is a broad term that covers a wide range of applications and technologies. AI technologies can be used to help doctors and other healthcare professionals diagnose and treat diseases, make predictions about patient health, and improve the efficiency of care delivery. AI is also being used to develop new drugs and personalized treatments, and to create digital assistants that can help patients manage their health.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS20011/

Artificial Intelligence in Healthcare Market: Key Trends and Drivers

The market is driven by several factors, including the need to manage data more effectively and optimize healthcare costs, the growth of public-private partnerships, and the increased regional spending on healthcare. Additionally, the market is anticipated to grow as opportunities in geriatric population care with AI technology, imaging, and diagnostics to generate data for research development arise. Moreover, the growing shortage of healthcare workforce drove the adoption of AI/ML technologies. Therefore, AI algorithms can be trained to analyze patient health information which further supports care providers in quickly diagnosing the condition and devising an accurate treatment regime.

Small-molecule drug discovery benefits from AI in four ways; access to new biology, improved or unique chemistry, higher success rates, and speedier and less expensive discovery procedures. For instance, FDA’s Center for Drug Evaluation and Research (CDER) approved 50 brand-new pharmaceutical and biological products in 2021. About 33 of the 50 novel medications and biological products approved for use had tiny molecules, while 17 were monoclonal antibodies and other large molecules. Such aforementioned factors boosting the growth of the market and accelerating the adoption rate of AI in healthcare.

Artificial Intelligence in Healthcare Market: Restraints & Challenges

The restraints in the AI in healthcare market are the lack of awareness and the high cost of AI-based solutions. The challenges in the AI in healthcare market are the lack of skilled workforce, the need for high initial investment, and the need for data security.

Artificial Intelligence in Healthcare Market Report Findings

https://www.globalinsightservices.com/reports/artificial-intelligence-in-healthcare-market/

The software segment is likely to hold a dominant Artificial Intelligence in Healthcare Market share and grow at a substantial CAGR during the forecast period.

Based on component, the market is segmented as hardware, software solution, and services. In 2022, the software solutions segment dominated the market due to the rapidly growing adoption rate of AI-based software solutions amongst healthcare providers, payers, and patients. For instance, in September 2019, GE Healthcare partnered with five Chinese local software developers namely, 12Sigma Technologies, Biomind, Shukun Technology, Yizhun Medial AI, and YITU Technology to collaboratively work on developing Edison AI platform and support the smooth digital transformation of GE Healthcare. Whereas, software solutions is anticipated to register the fastest growth rate over the forecast period. This dramatic growth rate is attributable to the rising penetration of AI-based technologies in several healthcare applications such as cybersecurity, clinical trials, virtual assistants, robot-assisted surgeries, telemedicine, dosage error reduction, and fraud detection.

The clinical trial segment is anticipated to hold a majority of the Artificial Intelligence in Healthcare Market size throughout the study period.

Based on application, the market is segmented as Robot-Assisted Surgery, Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow, Wearables, Virtual Assistants, and Others. Out of these, the clinical trials segment dominated the market in 2022 due to the growing number of patent expirations, rising demand for faster and accurate clinical trials to cater to the need for new drug discoveries and drug development. Although, prior to the pandemic AI-technologies in clinical trials were still in a nascent stage, now with the growth in demand for faster clinical trials supporting trial designing, study adherence, minimizing dropout rates, and patient recruitment, AI-based technologies in clinical trials has witnessed a surge in adoption. Decreasing the amount of time required in performing clinical trials and enhancing the accuracy and reliability of the clinical trial are expected to boost the market growth. Life science organizations, government regulatory authorities, and healthcare start-ups are beginning to support and adopt AI-empowered solutions in their processes. For example, Deep6AI is an AI monitoring system that enhances the patient recruitment process and reduces the time and expenses involved.

The Asia-Pacific region is estimated to exhibit the highest growth rate during the Artificial Intelligence in Healthcare Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America to hold significant market share. The high adoption rate of AI technologies across healthcare and pharma, the strong presence of prominent AI software and system suppliers, and the combined investment by government and private organizations in the improvement and growth of research and development activities are expected to drive the market’s demand in the United States. Over time, the country is expected to dominate the regional market due to its developed infrastructure that can house advanced medical solutions. The increasing inflow of investments in startups for AI implementation would accelerate the market’s growth.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS20011/

Competitive Landscape

The overall competitive rivalry remains moderately high in the market studied. The growing presence of big players in the industry is expected to intensify competitive rivalry during the forecast period. The global Artificial Intelligence in Healthcare Market report includes players such as AiCure, APIXIO, Inc., Atomwise, Inc, Butterfly Network, Inc., Cyrcadia Health Inc, Enlitic, Inc, IBM Corporation, iCarbonX, Insilico Medicine Inc, NVIDIA Corporation, others.

Recent Developments in the Artificial Intelligence in Healthcare Market:

• In September 2022, Novo Nordisk A/s and Microsoft collaborated to accelerate drug discovery and development using big data and artificial intelligence. The collaboration centers on expanding digital science and AI capability applications in the healthcare business and sustainability.
• In August 2022, Atomwise Inc. and Sanofi collaborated to advance AI research for computational discovery and make better medicines faster by unlocking up to five drug targets inaccessible to traditional small molecule discovery approaches.

Artificial Intelligence in Healthcare Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Artificial Intelligence in Healthcare Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Artificial Intelligence in Healthcare Market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Artificial Intelligence in Healthcare Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global Artificial Intelligence in Healthcare Market Segmentation

By Product

• Software Solutions
• Hardware
• Services

By Application

• Robot-Assisted Surgery
• Clinical Trials
• Hospital Workflow
• Therapy Planning
• Wearables
• Virtual Assistants
• Medical Imaging & Diagnosis
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• AiCure
• APIXIO, Inc
• Atomwise, Inc
• Butterfly Network, Inc
• Cyrcadia Health Inc
• Enlitic, Inc
• IBM Corporation
• iCarbonX
• Insilico Medicine Inc
• NVIDIA Corporation

Autotransfusion Devices Market to Reach USD 419.3 million by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, April 2023: According to a new research study by Global Insight Services (GIS), the global autotransfusion devices market is expected to grow rapidly over the next 10 years to reach a value of more than USD 419.3 million by 2032.

To collect and re-infuse the patient’s blood, autotransfusion devices are frequently employed. The use of autologous blood transfusions to prevent infections brought on by allogeneic blood transfusions is made possible by these systems, which play a significant part in cell salvage approaches. These tools are used in invasive procedures for the heart, the joints, the nervous system, obstetrics, and gynecology. Systems can be divided into intraoperative systems, post-operative systems, and dual-mode systems based on how usable they are.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10450/

Autotransfusion Devices Market: Key Trends and Drivers

Some of the major drivers anticipated to propel market expansion during the projected period include an increase in surgical operations, an increase in the number of surgical cases, and an increase in the number of liver or other organ transplant surgeries. Additionally, it is predicted that the market would expand due to the growing older population in the world as well as increased demand for cardiac devices. The rise in blood illnesses, the number of trauma and accident cases, and technological advancements all contribute to the growth of the blood transfusion device.

Autotransfusion Devices Market: Restraints and Challenges

The high cost associated with autotransfusion systems coupled with risk associated with autotransfusion market is anticipated to hinder the growth of the market.

Autotransfusion Devices Market Report Findings

https://www.globalinsightservices.com/reports/autotransfusion-devices-market-2/

The autotransfusion system segment is anticipated to dominate the market during the forecast period

Based on the product type, it is segmented into autotransfusion systems, and consumables & accessories. The autotransfusion system segment is anticipated to dominate the market during the forecast period. The rising adoption of autotransfusion systems in developed and developing countries owing to their efficiency in blood transfusion is anticipated to boost the growth of the segment.

The cardiovascular surgeries segment is anticipated to dominate the market during the forecast period

Based on the application, it is segmented into cardiovascular surgeries, orthopedic surgeries, neurological surgeries, obstetrics & gynecological surgeries, and others. The cardiovascular surgeries segment is anticipated to dominate the market during the forecast period. The increasing number of cardiovascular procedures, like coronary artery bypass grafting, implantable cardioverter-defibrillator & pacemaker implantations, heart transplantation, valve replacement surgeries, and others is anticipated to boost the growth of this segment.

The hospital segment is expected to dominate the market during the forecast period

Based on the end user, it is segmented into hospitals, specialty clinics & others. The hospital segment is expected to dominate the market during the forecast period. The increasing number of cardiovascular and obstetrics & gynecological surgeries carried out in hospitals is expected to boost the growth of the market during the forecast period.

The North American region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. The increasing use of autologous blood transfusion in major cardiovascular & orthopedic surgeries coupled with the presence of developed healthcare infrastructure is boosting the growth of the market.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10450/

Competitive Landscape

The key players studied in the report are LivaNova PLC (U.K.), Medtronic (Ireland), Haematonics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), BD (Becton, Dickinson, and Company) (U.S.), Beijing Jingjing Medical Equipment Co., Ltd. (China), and ProCell Surgical Inc. (U.S.) among others.

Autotransfusion Devices Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Autotransfusion Devices market outlook and estimations from 2021 to 2031, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Autotransfusion Devices market potential from 2021 to 2031 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Autotransfusion Devices market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Autotransfusion Devices industry.

Global Autotransfusion Devices Segmentation

By Product

• Autotransfusion Systems
• Consumables & Accessories

By Application

• Cardiovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Obstetrics & Gynecological Surgeries
• Others

By End User

• Hospitals
• Specialty Clinics & Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• LivaNova PLC (U.K.)
• Medtronic (Ireland)
• Haematonics Corporation (U.S.)
• Fresenius SE & Co. KGaA (Germany)
• BD (Becton, Dickinson, and Company) (U.S.)
• Beijing Jingjing Medical Equipment Co., Ltd. (China)
• ProCell Surgical Inc. (U.S.)

Clinical Trials Management System Market to Reach US$ 5.7 bn by 2032, driven by the increase in industry academic collaborations, rise in number of clinical trials, growth in technology in the healthcare sector, and increase in government support for research trials: Global Insight Services

New York, April 2023: According to a new research study by Global Insight Services (GIS), the global Clinical Trials Management System Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 5.7 bn by 2032.

A clinical trial management system (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials. The system aims to manage and maintain tracking of patient data. Clinical trial management systems incorporate different components consisting of software, hardware, and services. Clinical trial management system provides data to business intelligence system, which acts as access centralized data, thus reducing the number of delayed trials.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS20232/

Clinical Trials Management System Market: Key Trends and Drivers

Growth of the global clinical trial management market is majorly driven by increase in industry academic collaborations, rise in number of clinical trials, growth in technology in the healthcare sector, and increase in government support for research trials. In addition, growth in number of clinical trial management system (CTMS) is attributed to factors such as high prevalence of chronic diseases. Furthermore, products of clinical trial management system are efficient, easy to use, provide effective patient safety and regulatory compliances, and enhance financial management. For instance, in December 2020, Environmental Response Team (ERT), a global company specializing in clinical services, announced the launch of data insight to enhance the study effectiveness and efficiency. Moreover, in January 2020, Veeva, a cloud computing company, announced the launch of veeva vault payment software, which is an application used for veeva vault CTMS. Growth in number of clinical trials and increase in number of key players to develop advanced clinical trial management system (CTMS) solution drive the market growth.

Clinical Trials Management System Market: Restraints & Challenges

One of the key factors restraining the growth of the market is the lack of standardization in the clinical trial process. This lack of standardization can lead to errors and delays in the clinical trial process. The another key factors restraining is the lack of skilled personnel. This lack of skilled personnel can lead to delays in the clinical trial process. Moreover, the cost of clinical trials can be a major challenge in the CTMS market. The cost of clinical trials can be a barrier to entry for many companies.

Clinical Trials Management System Market Report Findings

https://www.globalinsightservices.com/reports/clinical-trial-management-system-market/

The software segment is anticipated to hold a majority of the Clinical Trials Management System Market size throughout the study period.

Based on the component, the Clinical Trials Management System Market is divided into software and services of these, software segment dominated the segment with a revenue share of xx% in 2022. The software helps perform critical functions such as comprehensive management of trial planning, country and site progress, monitoring activities, regulatory procedures, supplies, and finance. These are deployed mostly on a subscription basis at enterprise or site levels. Periodic software upgrades and add-ons may also add to the revenue. Furthermore, an effective CTMS software solution can help pharmaceutical and medical device companies comply with regulatory norms, which helps accelerate market entry. Hence, the software segment dominates the market as it helps to streamline and fine-tune the document management processes, which can otherwise compromise the data quality and participant safety. For instance, Clinion provides comprehensive software for clinical trial setup and management. The software comes with a host of integrated offerings including CTMS, IWRS/RTSM, EDC, and eCOA to meet the needs of small- and medium-sized companies.

The Licensed Enterprise segment is anticipated to hold a majority of the Clinical Trials Management System Market size throughout the study period.

By delivery mode, the industry is bifurcated into Web-based (On-demand), Licensed Enterprise (On-premises), and Cloud-based (SaaS). Licensed Enterprise segment dominated the market with the highest revenue share of xx% in 2022. This is due to the benefits such as remote access to data and minimal technical issues. These are the most preferred CTM systems. They help minimize costs associated with system security, backups, upgrades, and uptime consistency. Furthermore, web & cloud-based systems support the storage of large amounts of data as well as the centralization of data, which facilitates access to data from any location. These factors are expected to drive growth during the forecast period.

The Enterprise-wide CTMS segment is likely to hold a dominant Clinical Trials Management System Market share and grow at a substantial CAGR during the forecast period.

Based on deployment type, the industry is categorized into Enterprise-wide CTMS, and On-Site CTMS. Of these Enterprise-wide CTMS segment dominated the market with a revenue share of more than xx% in 2022. The key factors contributing to this share include associated benefits such as end-to-end insights into operational activities, such as accruals and deviations, scalability of the solution, robust reporting, enhanced billing compliance, and tracking and management of regulatory processes. For instance, RealTime Enterprise CTMS, offers a comprehensive solution for centralizing recruitment, eRegulatory, eSOURCE, accounting, and aggregate reporting across large site networks, universities, and hospitals. The network-wide visibility and oversight provided by enterprise-level solutions present an ideal solution for large biopharmaceutical companies and CROs.

The CRO’s segment is anticipated to hold a majority of the Clinical Trials Management System Market size throughout the study period.

Based on end-user, the Clinical Trials Management System Market is divided into Large Pharma-biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-sized Pharma-biotech Companies, Others. Among these, CROs segment dominated the livestock in the animal feed segment with the highest revenue share of xx% in 2022. The trends of globalization, digitalization, and personalized medicine have led to increased outsourcing & externalization of clinical trials by healthcare and life sciences companies to CROs. This is because it may not be feasible for sponsors to fulfill all operational requirements, especially with many trials being multinational. Partnerships with multinational companies or local CROs simplify this task. For instance, Clario offers solutions for all trial models: site-based, decentralized, and hybrid clinical trials. It generates rich, diverse, and reliable evidence via its 30 facilities spread across 9 countries in North America, Europe, and Asia Pacific.

The Asia Pacific region is estimated to exhibit the highest growth rate during the Clinical Trials Management System Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific dominated the market with the highest revenue share of over xx% in 2022. Asia Pacific is estimated to attain the fastest CAGR of about 18% in the next few years. This is owing to increasing R&D activities in the region, the availability of a large patient pool, an increasing number of clinical trials conducted across the region, and outsourcing of clinical trials. Asian countries offer a less expensive process for clinical research studies. This factor is anticipated to boost the regional market over the forecast period. Latin America is another emerging market for clinical trials. As per clinicaltrials.gov, an increasing number of clinical trials are being conducted in Latin American countries including Mexico, Brazil, and Argentina.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS20232/

Competitive Landscape

Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Clinical Trials Management System Market are Advarra, Inc. (US), Clario (US), Dassault Systèmes S.E. (Medidata) (France), DATATRAK International, Inc. (US), DSG, Inc. (US), Elligo Health Research (US), MasterControl Solutions, Inc. (US), Oracle Corporation (US), Parexel International Corporation (US), and Veeva Systems Inc. (US), among others.

Recent Developments in the Clinical Trials Management System Market:

• In October 2022, Veeva Systems partnered with about 40 CROs to deploy its suite of clinical trial management tools, including the Veeva Vault CTMS.
• In November 2021, a clinical endpoint technology leader, ERT, merged with Bioclinica to form Clario. This enabled the company to deliver technology-based therapeutic area solutions to meet clinical trial objectives.
• In March 2021, Peachtree BioResearch Solutions, Inc., a CRO serving emerging mid-sized companies, adopted Oracle Health Sciences Cloud Services and the Siebel Clinical Trial Management System (CTMS) to streamline clinical trials start-up and monitoring.
• In February 2021, eClinical Solutions LLC launched elluminate CTMS for life sciences companies to support drug development.

Clinical Trials Management System Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Clinical Trials Management System Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Clinical Trials Management System Market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Clinical Trials Management System Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global Clinical Trials Management System Market Segmentation

By Component

• Software
• Services

By Delivery Mode

• Web-based (On-demand)
• Licensed Enterprise (On-premises)
• Cloud-based (SaaS)

By Deployment Type

• Enterprise-wide CTMS
• On-Site CTMS

By End-user

• Large Pharma-biotech Companies
• CROs
• Medical Device Manufacturers
• Small & Mid-sized Pharma-biotech Companies
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• Advarra, Inc. (US)
• Clario (US)
• Dassault Systèmes S.E. (Medidata) (France)
• DATATRAK International, Inc. (US)
• DSG, Inc. (US)
• Elligo Health Research (US)
• MasterControl Solutions, Inc. (US)
• Oracle Corporation (US)
• Parexel International Corporation (US)
• Veeva Systems Inc. (US)

mHealth Market to Reach US$ 209.4 Bn by 2032, driven by increasing penetration of the internet and smartphones and growing adoption of mHealth technology and platforms by physicians and patients

New York, April 2023: According to a new research study by Global Insight Services (GIS), the global MHealth Market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 209.4 Billion by 2032.

mHealth is defined as a separate branch of eHealth, which deals with the collection of patient data. This patient data is collected through wireless electronic means such as cell phones, wearable and other mHealth devices. In addition, the collected patient data is stored in the cloud remotely using mHealth application. This stored data is made available to healthcare professionals for the purpose of analyzing health-related parameters. For example, the mHealth Blood Pressure Monitor collects data related to patient BP fluctuations. These values are immediately checked by healthcare professionals to determine the severity of the condition. In addition, various types of medical devices and services are available in the market. For example, blood glucose monitor, BP monitor, pulse oximetry, neurological monitoring, heart monitor, apnea and sleep monitor, and others.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS21175/

Digital Power Utility Market: Key Trends and Drivers

The rising focus on improving personal health and fitness using smart devices and wearables is the major factor accelerating market growth. Besides, increasing penetration of the internet and smartphones and growing adoption of mHealth technology and platforms by physicians and patients are also anticipated to propel market growth. Furthermore, the rising penetration of digital health services for remote patient monitoring is also increasing the demand for mobile health apps, which in turn is expected to propel market growth over the forecast years. In addition, the increasing use of smartphones among the adult population and teenagers is also anticipated to drive the growth of mHealth platforms and technologies in the upcoming years. Moreover, the shift in trend from conventional healthcare practices to patient-centric and preventive approaches is also anticipated to drive the market for mHealth over the years. The high preference for mobile medical platforms and the positive attitude of healthcare professionals toward real-time patient care are also likely to accelerate the growth of the market during the forecast year.

Digital Power Utility Market: Restraints & Challenges

Privacy and data security concerns are some of the factors anticipated to hamper the adoption of mHealth technologies. Data accessibility issues, configuration changes, data breaches, and the leakage of sensitive health information are the concerns expected to impede market growth. For example, in 2019, the personal and medical data of about 24.4 million people was leaked by the American Medical Collection Agency (AMCA), a medical bill collector for several companies. However, this type of restraint is expected to reduce during forecast periods with the government imposing stringent regulations on the market players regarding data privacy.

MHealth Market Report Findings

https://www.globalinsightservices.com/reports/mhealth-market/

The apps segment is likely to hold a dominant MHealth Market share and grow at a substantial CAGR during the forecast period.

By product & services, the MHealth Market is segmented into mHealth Apps, Connected Medical Devices, mHealth Services. The mHealth Apps segment held the largest market share of xx% in 2022 and is expected to grow at a significant CAGR over the forecast period. The mHealth apps segment dominated the market for mHealth and accounted for the largest revenue share of 76.5% in 2022. Increasing penetration of the internet and smartphones and the growing adoption of mobile health apps by healthcare professionals and the patient population are the factors responsible for the high market value of the segment. Furthermore, growing awareness regarding mobile health apps for remote patient monitoring, patient tracking, medication management, disease management, fitness and wellness, women’s health, personal health record management, etc. are also anticipated to drive the fastest CAGR during the forecast period.

The Providers segment is likely to hold a dominant MHealth Market share and grow at a substantial CAGR during the forecast period.

By end-user, the MHealth Market is segmented into mHealthcare Providers & Payers, Patients/Consumers, Others. The mHealthcare Providers & Payers segment is projected to emerge as one of the fastest-growing segments in the market for next-generation mHealth over the forecast period. An increase in the number of mobile subscribers and improvements in network infrastructure are major factors responsible for the highest share of the segment. In addition, rising 3G and 4G technologies and growing industry consolidation activities by the leading players are also anticipated to drive the segment over the forecast years. Additionally, the increasing trend of using smartphones, coupled with the rapid development of several healthcare mobile apps are the factors likely to boost the growth of this segment. Furthermore, direct involvement of content players for the development of medical health applications and technologies, documentation handling, remote patient monitoring, health activity tracking, and appointment scheduling are also anticipated to drive the segment growth over the forecast years.

The North America region is estimated to exhibit the highest growth rate during the MHealth Market forecast period.

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America dominated the market for mHealth and accounted for the largest revenue share of 37.1% in 2022 owing to several factors, which include growing healthcare expenditure, increasing incidences of chronic diseases, rising geriatric population, and highly developed network infrastructure. In addition, favorable government initiatives and the growing adoption of mobile healthcare applications are accelerating the demand for mHealth services in the region. Moreover, the rising burden of cardiovascular diseases in the region is driving the demand for real-time monitoring. The availability of mHealth apps that can provide real-time information related to cardiovascular health can prevent major health issues and reduce the death rate due to sudden cardiac arrest.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS21175/

Competitive Landscape

The key players in the market are AgaMatrix, Inc. (US), AIRSTRIP TECHNOLOGIES, INC. (US), Apple Inc. (US), AT&T Inc. (US), athenahealth, Inc. (US), iHealth Labs, Inc. (US), Koninklijke Philips N.V. (Netherlands), Medtronic (US), OMRON HEALTHCARE Co., Ltd. (Japan), and TrueCare24, Inc. (US), among other.

Recent Developments in the Digital Power Utility Market:

• In August 2022, Kaiser Permanente of the Northwest and Medical Teams International launched an innovative initiative, namely Kaiser Permanente Care & Connect, that will provide mobile healthcare services to marginalized populations throughout the Pacific Northwest.
• In June 2022, Orange Health launched its diagnostic services in New Delhi, India, as part of its ambitious geographical expansion plan. With this launch, customers across the NCR region can avail of a wide range of diagnostic services in just 60 minutes from the comfort of their homes, with reports in six hours.
• In August 2020, Allscripts entered into a partnership with Sheba Medical Center for the development of AI-based technology in the mHealth market.
• In September 2019, Apple Inc. introduced a mHealth app research to assist the researchers in clinical studies.

MHealth Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global MHealth Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future MHealth Market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the MHealth Market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global surface disinfectants industry.

Global MHealth Market Segmentation

By Product & Services

• mHealth Apps
• Medical Apps
• Fitness Apps
• Connected Medical Devices
• Vital Signs Monitoring Devices
• Peak Flow Meters
• Sleep Apnea Monitors
• Multiparameter Trackers
• Fetal Monitoring Devices
• Neurological Monitoring Devices
• Others

mHealth Services

• Remote Monitoring Services
• Diagnosis & Consultation Services
• Treatment Services
• Healthcare System Strengthening Services
• Fitness & Wellness Services
• Prevention Services

By End-user

• Healthcare Providers & Payers
• Patients/Consumers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of World
  • Latin America
  • Middle East
  • Africa

Key Players

• AgaMatrix, Inc. (US)
• AIRSTRIP TECHNOLOGIES, INC. (US)
• Apple Inc. (US)
• AT&T Inc. (US)
• athenahealth, Inc. (US)
• iHealth Labs, Inc. (US)
• Koninklijke Philips N.V. (Netherlands)
• Medtronic (US)
• OMRON HEALTHCARE Co., Ltd. (Japan)
• TrueCare24, Inc. (US)

Dental Scalers Market to Reach USD 1,658 Million by 2032, driven by the growth in investment in healthcare infrastructure across the globe: Global Insight Services

New York, April 2023: According to a new research study by Global Insight Services (GIS), the global dental scalers market is expected to grow rapidly over the next 10 years to reach a value of more than USD 1,658 million by 2032.

Dental Scalar is a specialized dental instrument used by oral health professionals to remove dental plaque, calculus (tartar), and other debris from the surfaces of teeth. It is an essential tool in dental cleanings and periodontal treatments, aiming to maintain optimal oral hygiene and prevent periodontal diseases. Dental scalers typically have sharp, curved tips designed to access hard-to-reach areas around the teeth and gums. During the scaling procedure, the dental scaler’s tip is gently applied to the tooth surface, effectively dislodging and scraping away the accumulated plaque and calculus. By removing these harmful deposits, dental scalers aid in reducing the risk of gum disease, tooth decay, and other oral health issues, promoting overall oral well-being for patients.

Request Sample Pages of this Research Report:

https://www.globalinsightservices.com/request-sample/GIS10425/

Dental Scalers Market: Key Trends and Drivers

Increasing prevalence of oral health issues and the growing awareness of the importance of oral hygiene. As dental conditions such as plaque buildup, tartar formation, and gum disease become more common, the demand for efficient and effective dental scalars rises. Additionally, advancements in technology and product innovation have led to the development of sophisticated dental scalar devices, offering better precision, ease of use, and patient comfort. Dental professionals are increasingly adopting these advanced tools to enhance their treatment capabilities, driving market growth. Furthermore, the rising geriatric population, with a higher propensity for dental problems, further contributes to the expanding market as dental scalars become a vital tool in geriatric oral care.

Dental Scalers Market: Restraints and Challenges

One significant restraint in the dental scaler market is the high cost associated with advanced dental scaling equipment and technologies. Dental scalers, which are essential tools for removing plaque and tartar from teeth, have seen considerable advancements in recent years, incorporating features like ultrasonic technology and ergonomic designs. However, the implementation of these innovations often results in higher production costs, which subsequently translate to elevated prices for dental professionals and consumers. The cost barrier may hinder smaller dental practices or those in economically constrained regions from adopting the latest scaler technologies, limiting their ability to provide the most cutting-edge dental care to their patients. Additionally, the high costs could also deter potential buyers from upgrading their existing equipment, thereby impacting the overall market growth for dental scalers. Manufacturers and stakeholders in the dental industry will need to find ways to balance technological advancements with affordability to address this restraint effectively.

Dental Scalers Market Report Findings

https://www.globalinsightservices.com/reports/dental-scalers-market/

The powered dental scalers segment is anticipated to dominate the market during the forecast period

Based on the product, it is segmented into powered dental scalers, handheld dental scalers, and scalers inserts. The powered dental scalers segment is anticipated to dominate the market during the forecast period. These innovative devices offer advanced features and enhanced efficiency compared to traditional manual scalers, leading to increased demand from dental professionals and patients alike. Powered dental scalers provide more precise and consistent scaling, reducing the risk of dental plaque and calculus buildup, thereby promoting better oral health outcomes. Their ergonomic design and ease of use also contribute to their popularity among dental practitioners, leading to improved patient experience during dental procedures. As the dental industry continues to embrace technological advancements, the powered dental scaler segment is expected to drive continued growth in the dental scaler market, benefiting both dental professionals and patients with superior oral care solutions.

The periodontics segment is anticipated to dominate the market during the forecast period

Based on the application, it is segmented into periodontics, endodontics, and others. The periodontics segment is anticipated to dominate the market during the forecast period. This surge can be attributed to several factors, including an increasing awareness of the importance of periodontal health and its impact on overall well-being. Dental professionals and patients alike have become more cognizant of the significance of early detection and intervention in preventing and treating periodontal diseases. Moreover, advancements in dental scalar technology have led to the development of more efficient and effective instruments, promoting better patient outcomes and enhanced treatment experiences. The rising prevalence of periodontal issues, particularly in aging populations, has also driven the demand for periodontics products and services. As the emphasis on oral hygiene continues to grow, the periodontics segment is expected to maintain its upward trajectory in the dental scalar market, offering promising opportunities for industry players and stakeholders alike.

The hospitals segment is anticipated to dominate the market during the forecast period

Based on the end user, it is segmented into hospitals, dental clinics, and others. The hospitals segment is anticipated to dominate the market during the forecast period. The increasing awareness of oral hygiene and the rising prevalence of dental disorders have led to a surge in hospital visits for dental care and treatments. Hospitals, with their advanced infrastructure, skilled professionals, and comprehensive services, have become a preferred choice for patients seeking dental scaler procedures. Additionally, the integration of advanced technologies in dental scaler equipment and procedures, along with a growing elderly population susceptible to dental issues, has further propelled the hospital segment’s expansion in the dental scaler market. As hospitals continue to invest in state-of-the-art dental care facilities and focus on patient-centric approaches, the hospital segment is expected to sustain its impressive growth trajectory in the dental scaler market in the foreseeable future.

The North America region is anticipated to dominate the market during the forecast period

Region-wise, it is studied across the North America, Europe, Asia Pacific, and the Rest of the World. The North America region is anticipated to dominate the market during the forecast period. Throughout the projected period, the region is anticipated to maintain its dominance in the worldwide dental scalers market. The strategic presence of major players in the U.S. and Canada as well as the increase in the use of technologically advanced dental tools by dental practitioners in the region are factors that contribute to North America’s dominance. Moreover, a high emphasis on good oral health and the development of preventive dental treatments. In addition, 85.0% of people in the U.S. appreciate their dental health and good oral health to be a critical part of the overall treatment. The combination of the above factors is expected to drive the region’s market growth over the forecast period. However, it is anticipated that the growth of the dental scalers market in Asia Pacific will be boosted by an expansion of the patient pool and a rise in public awareness of oral health.

Have a question for our analyst:

https://www.globalinsightservices.com/inquiry-before-buying/GIS10425/

Competitive Landscape

The report analyses the major players such as Henry Schein, Inc., Dentsply Sirona, COLTENE Group, EMS Medical, Hu-Friedy Mfg. Co., LLC, Parkell, Inc., Nordent Manufacturing, Inc., APOZA, Kerr Corporation, and Micron Corporation, among others.

Recent Developments

• In September 2022, The ultrasonic scaler features enhanced infection control and an open platform for other brand inserts. The scaler is built around a new IntelliSense processor to ensure consistent performance with all 30k inserts.
• In January 2021, Xiaomi launched the Sunuo T11 Pro Smart Visual Ultrasonic Dental Scaler under crowdfunding on the Youpin platform. It is a portable ultrasonic scaler that can be used right in the home without visiting dental clinics.
• In July 2017, OSUNG launched a torque wrench and ultrasonic scaler tips compatible with EMS and SATELEC systems.

Dental Scalers Market Report Coverage

• The report offers a comprehensive quantitative as well as qualitative analysis of the current global Dental Scalers market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
• A thorough analysis of market trends and restraints is provided.
• Region-wise, as well as country-wise conditions, are broadly evaluated in this report.
• The forecasts in this report are made by examining the recent trends along with future Dental Scalers market potential from 2022 to 2032 in terms of revenue.
• Porter’s five forces analysis, SWOT analysis, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Dental Scalers market are also analyzed.
• Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the global Dental Scalers industry.

Global Dental Scalers Market Segmentation

By Product

• Powered Dental Scalers
• Handheld Dental Scalers
• Scaler Inserts

By Application

• Periodontics
• Endodontics
• Others

By End User

• Hospitals
• Dental Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • The UK
  • Germany
  • France
  • Spain
  • Rest of Europe
• The Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World
  • Latin America
  • The Middle East
  • Africa

Key Players

• Henry Schein, Inc.
• Dentsply Sirona
• COLTENE Group
• EMS Medical
• Hu-Friedy Mfg. Co., LLC
• Parkell, Inc.
• Nordent Manufacturing, Inc.
• Micron Corporation
• APOZA
• Kerr Corporation